[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 178
1. Kang Y, Moressi CJ, Scheetz TE, Xie L, Tran DT, Casavant TL, Ak P, Benham CJ, Davidson BL, McCray PB Jr: Integration site choice of a feline immunodeficiency virus vector. J Virol; 2006 Sep;80(17):8820-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FIV integration preferences are more similar to those of primate lentiviruses and distinct from those of Moloney murine leukemia virus, avian sarcoma leukosis virus, and foamy virus.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Apr;79(8):5211-4 [15795304.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] J Biol Chem. 2005 May 6;280(18):17841-7 [15749713.001]
  • [Cites] Gene Ther. 2005 Jul;12(14):1089-98 [16003340.001]
  • [Cites] Blood. 2005 Sep 1;106(5):1552-8 [15886327.001]
  • [Cites] J Virol. 2005 Oct;79(19):12199-204 [16160146.001]
  • [Cites] J Virol. 2004 Sep;78(17):9524-37 [15308744.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Mol Biol. 1992 Jun 5;225(3):835-47 [1602485.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2999-3003 [8385354.001]
  • [Cites] Nat Med. 1998 Mar;4(3):354-7 [9500613.001]
  • [Cites] J Virol. 1999 Jun;73(6):4991-5000 [10233961.001]
  • [Cites] Nat Med. 2005 Dec;11(12):1287-9 [16311605.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1498-503 [16428288.001]
  • [Cites] J Clin Invest. 1999 Dec;104(11):R55-62 [10587528.001]
  • [Cites] Mol Ther. 2001 Jun;3(6):850-6 [11407898.001]
  • [Cites] Hum Gene Ther. 2001 Nov 20;12(17):2109-19 [11747600.001]
  • [Cites] Mol Ther. 2002 Jan;5(1):16-24 [11786041.001]
  • [Cites] Hum Gene Ther. 2002 Apr 10;13(6):689-96 [11936968.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6216-21 [11959904.001]
  • [Cites] J Virol. 2002 Sep;76(18):9378-88 [12186920.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] J Gene Med. 2002 Sep-Oct;4(5):463-9 [12221638.001]
  • [Cites] J Mol Biol. 2002 Oct 25;323(3):441-52 [12381300.001]
  • [Cites] N Engl J Med. 2003 Jan 16;348(3):255-6 [12529469.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • (PMID = 16912328.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL079023; United States / NHLBI NIH HHS / HL / HL-51670; United States / NHLBI NIH HHS / HL / P01 HL051670; United States / NHLBI NIH HHS / HL / R01 HL075363; United States / NIGMS NIH HHS / GM / R01 GM068903; United States / NHLBI NIH HHS / HL / HL-75363; United States / NHLBI NIH HHS / HL / HL-79023
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Other-IDs] NLM/ PMC1563849
  •  go-up   go-down


2. Veselý P, Blase C, Matouskova E, Bereiter-Hahn J: Arising podosomal structures are associated with neoplastic cell morphological phenotype induced by the microenvironment. Anticancer Res; 2006 Mar-Apr;26(2A):967-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Increased numbers of rosettes of podosomes were observed in overgrown rat Rous sarcoma RsK4 cells.
  • [MeSH-major] Cell Movement / physiology. Cell Surface Extensions / physiology. Sarcoma, Avian / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619494.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Actins; 0 / Culture Media
  •  go-up   go-down


3. Bruce JW, Bradley KA, Ahlquist P, Young JA: Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. J Virol; 2005 Oct;79(20):12969-78
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When engineered to express the TVA receptor for subgroup A avian sarcoma and leukosis virus (ASLV-A), the five cell lines were resistant to infection with a MLV vector pseudotyped with the ASLV-A envelope protein but were fully susceptible to infection with an ASLV-A vector.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Dec;74(23):10965-74 [11069991.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72 [10449786.001]
  • [Cites] J Virol. 1999 Nov;73(11):8919-25 [10515996.001]
  • [Cites] EMBO J. 2004 Nov 24;23(23):4670-8 [15510219.001]
  • [Cites] Retrovirology. 2004;1:30 [15453907.001]
  • [Cites] J Virol. 2001 Apr;75(8):3520-6 [11264341.001]
  • [Cites] J Virol. 2001 Apr;75(8):3626-35 [11264352.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1754-64 [11285238.001]
  • [Cites] Nature. 2001 Nov 8;414(6860):225-9 [11700562.001]
  • [Cites] J Gene Med. 2001 Nov-Dec;3(6):517-28 [11778899.001]
  • [Cites] Nature. 2002 Aug 8;418(6898):646-50 [12167863.001]
  • [Cites] J Virol. 2002 Dec;76(23):12376-80 [12414981.001]
  • [Cites] J Cell Biol. 2002 Nov 11;159(3):441-52 [12417576.001]
  • [Cites] J Virol. 2003 Feb;77(3):1820-9 [12525616.001]
  • [Cites] J Virol. 2003 Feb;77(3):1977-83 [12525631.001]
  • [Cites] J Virol. 2003 Apr;77(8):5030-6 [12663813.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;281:179-208 [12932078.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;281:209-38 [12932079.001]
  • [Cites] J Virol. 2003 Dec;77(24):13084-92 [14645565.001]
  • [Cites] Nature. 2004 Feb 26;427(6977):848-53 [14985764.001]
  • [Cites] J Virol. 2004 Apr;78(7):3753-62 [15016895.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 18;101(20):7721-6 [15128947.001]
  • [Cites] Nat Immunol. 2004 Nov;5(11):1109-15 [15496950.001]
  • [Cites] J Virol. 1978 Jan;25(1):104-4 [202729.001]
  • [Cites] Cell. 1978 Aug;14(4):1007-13 [688393.001]
  • [Cites] Cell. 1978 Dec;15(4):1383-95 [215324.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] Mutat Res. 1982 Aug;95(2-3):297-311 [6289092.001]
  • [Cites] J Virol. 1982 Sep;43(3):871-5 [6292466.001]
  • [Cites] Cell. 1983 Feb;32(2):639-46 [6297804.001]
  • [Cites] J Virol. 1989 Jun;63(6):2629-37 [2724412.001]
  • [Cites] J Virol. 1989 Jun;63(6):2844-6 [2724414.001]
  • [Cites] Cell. 1990 Apr 20;61(2):213-22 [2331748.001]
  • [Cites] J Virol. 1992 Aug;66(8):5110-3 [1321291.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] J Virol. 1993 Apr;67(4):1811-6 [8383211.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11241-5 [7972042.001]
  • [Cites] Nature. 1996 Aug 29;382(6594):826-9 [8752279.001]
  • [Cites] J Virol. 1996 Nov;70(11):7510-6 [8892869.001]
  • [Cites] J Virol. 1998 Mar;72(3):2125-31 [9499068.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15270-4 [9860958.001]
  • [Cites] Arch Biochem Biophys. 1999 May 15;365(2):199-210 [10328813.001]
  • [Cites] Mol Biol Cell. 1999 Jun;10(6):1705-17 [10359591.001]
  • [Cites] EMBO J. 1999 Sep 1;18(17):4700-10 [10469649.001]
  • (PMID = 16188999.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA70810; United States / NCI NIH HHS / CA / T32 CA009075; United States / NCI NIH HHS / CA / P01 CA022443; United States / NCI NIH HHS / CA / R01 CA070810; United States / NCI NIH HHS / CA / CA22443
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1235846
  •  go-up   go-down


Advertisement
4. Suzuki K, Matsumoto T, Kobayashi E, Uenishi H, Churkina I, Plastow G, Yamashita H, Hamasima N, Mitsuhashi T: Genotypes of chicken major histocompatibility complex B locus associated with regression of Rous sarcoma virus J-strain tumors. Poult Sci; 2010 Apr;89(4):651-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genotypes of chicken major histocompatibility complex B locus associated with regression of Rous sarcoma virus J-strain tumors.
  • The chicken MHC-B locus affects the response to several strains of Rous sarcoma virus (RSV).
  • We evaluated the association between haplotypes of the MHC-B locus and responses to the J strain of RSV by using an F(2) experimental resource family constructed with tumor-regressive (White Leghorn) and tumor-progressive (Rhode Island Red) chickens.
  • Two haplotypes in the resource family, one associated with tumor regression and one with progression, were defined by these 2 markers.
  • [MeSH-major] Chickens / genetics. Major Histocompatibility Complex / genetics. Sarcoma, Avian / genetics
  • [MeSH-minor] Animals. Chromosome Mapping. DNA Primers. Genetic Markers. Genotype. Haplotypes / genetics. Haplotypes / immunology. Polymorphism, Single Nucleotide. Rous sarcoma virus / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20308396.001).
  • [ISSN] 0032-5791
  • [Journal-full-title] Poultry science
  • [ISO-abbreviation] Poult. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Genetic Markers
  •  go-up   go-down


5. Wu X, Qin A, Qian K, Jin W, Shao H, Zhu Y, Shen H: [Full-length cDNA sequence analysis of avian leukosis viruses subgroup J isolated from chickens with clinical hemangioma]. Wei Sheng Wu Xue Bao; 2010 Sep;50(9):1264-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Full-length cDNA sequence analysis of avian leukosis viruses subgroup J isolated from chickens with clinical hemangioma].
  • OBJECTIVE: To understand the molecular characteristics of subgroup J Avian Leukosis Viruses (ALV-J) isolated from chickens with clinical hemangioma, as well as to get more information for controlling the spread of ALV-J in layer chickens flocks.
  • We noted a special 19bp insertion mutation in Primer Binding Site (PBS)-Leader sequences in both JS09GY3 and JS09GY6 isolates from layer chickens with hemangioma and ML, which sequence was same to Rous Associated Virus type 1 (RAV-1), Rous Associated Virus type 2 (RAV-2) and Rous sarcoma virus (strain Schmidt-Ruppin B) (RSV-SRB).
  • We found some special mutation sites in U3, DR1 and the E element showed some potential relationship with the host breeds and the tumor phenotype, which function needs to be investigated in future.
  • [MeSH-major] Avian Leukosis Virus / genetics. Avian Leukosis Virus / isolation & purification. Hemangioma / virology

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21090269.001).
  • [ISSN] 0001-6209
  • [Journal-full-title] Wei sheng wu xue bao = Acta microbiologica Sinica
  • [ISO-abbreviation] Wei Sheng Wu Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / DNA, Viral
  •  go-up   go-down


6. Schulten ES, Briles WE, Taylor RL Jr: Rous sarcoma growth in lines congenic for major histocompatibility (B) complex recombinants. Poult Sci; 2009 Aug;88(8):1601-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rous sarcoma growth in lines congenic for major histocompatibility (B) complex recombinants.
  • Rous sarcoma virus (RSV)-induced tumor growth was examined in congenic lines of chickens with different major histocompatibility (B) complex recombinant haplotypes on the highly inbred line UCD 003 (B17B17) genetic background.
  • Each bird was assigned a tumor profile index (TPI) based on the 6 tumor size scores.
  • Least squares ANOVA was used to evaluate rank-transformed TPI values and mean tumor sizes through a repeated measures design.
  • Tumor growth and TPI values were greater for 003.R1 and 003.R4 chickens than for the other 3 congenic lines.
  • Among serologically similar recombinants 003.R2 and 003.R4, higher tumor growth and TPI in 003.R4 indicate unique genetic variation affecting RSV tumors compared with 003.R2.
  • The similar tumor growth of 003.R5 and 003.R6 chickens, which have BF/BL21 but different BG regions, demonstrated no BG effect on RSV tumors.
  • [MeSH-major] Chickens / genetics. Genetic Predisposition to Disease. Major Histocompatibility Complex / genetics. Poultry Diseases / genetics. Sarcoma, Avian / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19590074.001).
  • [ISSN] 0032-5791
  • [Journal-full-title] Poultry science
  • [ISO-abbreviation] Poult. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


7. Sakaue K, Harada H, Matsuda Y: Development of gene expression system in a marine diatom using viral promoters of a wide variety of origin. Physiol Plant; 2008 May;133(1):59-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Promoter sequences of the cytomegalovirus (PCMV), the rous sarcoma virus long terminal repeat (PRSV-LTR) and the cauliflower mosaic virus 35s (PCaMV35s) were ligated with the beta-glucuronidase (GUS) gene, uidA, and were introduced into cells of the marine diatom, Phaeodactylum tricornutum.
  • These results indicate that a wide spectrum of viral promoters originating from mammalian, avian and plant hosts can operate as constitutive promoters in a marine diatom.

  • Hazardous Substances Data Bank. Carbon dioxide .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18346072.001).
  • [ISSN] 1399-3054
  • [Journal-full-title] Physiologia plantarum
  • [ISO-abbreviation] Physiol Plant
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Viral; 142M471B3J / Carbon Dioxide; EC 3.2.1.31 / Glucuronidase; EC 4.2.1.1 / Carbonic Anhydrases
  •  go-up   go-down


8. Lee SK, Nagashima K, Hu WS: Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication. J Virol; 2005 Apr;79(7):4159-69
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To probe the functions of p12 in the early steps of MLV replication, we tested whether p12 can be replaced by spleen necrosis virus (SNV) p18, human immunodeficiency virus type 1 p6, or Rous sarcoma virus p2b.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell. 1989 Oct 6;59(1):103-12 [2676191.001]
  • [Cites] J Virol. 1992 Oct;66(10):5959-66 [1326652.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] J Virol. 1994 Aug;68(8):5013-8 [8035501.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9564-8 [7937806.001]
  • [Cites] J Cell Sci. 1995 Sep;108 ( Pt 9):3039-50 [8537443.001]
  • [Cites] Virology. 1996 Aug 15;222(2):339-51 [8806518.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Mol Biol. 1997 May 2;268(2):250-60 [9159468.001]
  • [Cites] Rev Sci Tech. 1998 Apr;17(1):269-77 [9638816.001]
  • [Cites] Trends Biochem Sci. 1998 Aug;23(8):297-301 [9757830.001]
  • [Cites] J Virol. 1999 Mar;73(3):2270-9 [9971810.001]
  • [Cites] EMBO J. 1999 Sep 1;18(17):4700-10 [10469649.001]
  • [Cites] J Virol. 1999 Oct;73(10):8185-95 [10482569.001]
  • [Cites] J Biol Chem. 1999 Sep 24;274(39):27997-8002 [10488150.001]
  • [Cites] J Virol. 1999 Nov;73(11):9170-7 [10516024.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] J Virol. 2000 Oct;74(20):9571-9 [11000228.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Mar;75(6):2616-26 [11222684.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] AIDS. 2001;15 Suppl 5:S13-20 [11816161.001]
  • [Cites] Virology. 1995 Apr 1;208(1):234-41 [11831705.001]
  • [Cites] J Virol. 2002 Aug;76(15):7473-84 [12097560.001]
  • [Cites] J Virol. 2002 Nov;76(21):10801-10 [12368323.001]
  • [Cites] J Virol. 2003 Jan;77(1):754-61 [12477882.001]
  • [Cites] Trends Cell Biol. 2002 Dec;12(12):569-79 [12495845.001]
  • [Cites] J Virol. 2003 Jan;77(2):1469-80 [12502862.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Aug;78(16):8486-95 [15280457.001]
  • [Cites] Nature. 1970 Jun 27;226(5252):1211-3 [4316301.001]
  • [Cites] J Gen Virol. 1974 Oct;25(1):21-9 [4372315.001]
  • [Cites] Gene. 1983 Nov;25(2-3):179-88 [6319235.001]
  • [Cites] J Virol. 1986 Aug;59(2):284-91 [3016298.001]
  • [Cites] Mol Cell Biol. 1986 Aug;6(8):2895-902 [3785217.001]
  • [Cites] Mol Cell Biol. 1987 Jan;7(1):379-87 [3031469.001]
  • [Cites] J Virol. 1988 May;62(5):1808-9 [3357211.001]
  • [Cites] Genes Dev. 1989 Apr;3(4):469-78 [2721960.001]
  • [Cites] Science. 1994 Feb 11;263(5148):802-5 [8303295.001]
  • [Cites] J Virol. 1991 Jan;65(1):162-9 [1845882.001]
  • (PMID = 15767417.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / DNA, Circular; 0 / DNA, Viral; 0 / Gag protein p12, moloney murine leukemia virus; 0 / Gene Products, gag; 0 / RNA, Viral; 0 / Viral Proteins; 0 / gag Gene Products, Human Immunodeficiency Virus; 0 / p6 gag protein, Human immunodeficiency virus 1
  • [Other-IDs] NLM/ PMC1061564
  •  go-up   go-down


9. Kohoutová Z, Rumlová M, Andreánsky M, Sakalian M, Hunter E, Pichová I, Ruml T: The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus. Virology; 2009 Feb 5;384(1):59-68
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the requirements for individual precursors in retrovirus assembly, we modified the polyprotein repertoire of Mason-Pfizer monkey virus (M-PMV) by mutating the frameshift sites to imitate the polyprotein organization of Rous sarcoma virus (Gag-Pro and Gag-Pro-Pol) or Human immunodeficiency virus (Gag and Gag-Pro-Pol).
  • For the "Rous-like" virus, assembly was impaired with no incorporation of Gag-Pro-Pol into particles and for the "HIV-like" virus an altered morphogenesis was observed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5331-6 [11959986.001]
  • [Cites] J Virol. 2002 May;76(9):4321-30 [11932398.001]
  • [Cites] J Virol. 2003 Jul;77(14):7779-85 [12829817.001]
  • [Cites] J Mol Biol. 2003 Aug 15;331(3):571-83 [12899829.001]
  • [Cites] Traffic. 2003 Oct;4(10):660-70 [12956869.001]
  • [Cites] Traffic. 2003 Oct;4(10):671-80 [12956870.001]
  • [Cites] J Virol. 2004 May;78(10):5023-31 [15113883.001]
  • [Cites] Virology. 1984 Oct 30;138(2):260-75 [6333757.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Mar;82(6):1618-22 [3885215.001]
  • [Cites] Science. 1985 Dec 13;230(4731):1237-42 [2416054.001]
  • [Cites] Cell. 1986 May 9;45(3):375-85 [2421920.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Jun;84(12):4298-302 [3035577.001]
  • [Cites] J Virol. 1988 Jun;62(6):2179-82 [2452901.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] Cell. 1989 Oct 6;59(1):103-12 [2676191.001]
  • [Cites] J Virol. 1990 Jun;64(6):2653-9 [2186175.001]
  • [Cites] J Virol. 1991 Sep;65(9):5111-7 [1870215.001]
  • [Cites] J Gen Virol. 1991 Oct;72 ( Pt 10):2509-17 [1919528.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):713-7 [1309954.001]
  • [Cites] J Biol Chem. 1992 May 15;267(14):9481-90 [1315755.001]
  • [Cites] J Virol. 1992 Jun;66(6):3873-8 [1316486.001]
  • [Cites] J Virol. 1992 Jul;66(7):4220-7 [1602542.001]
  • [Cites] J Virol. 1992 Nov;66(11):6304-13 [1383561.001]
  • [Cites] J Virol. 1993 Apr;67(4):2266-75 [8445731.001]
  • [Cites] Virology. 1993 Apr;193(2):661-71 [7681610.001]
  • [Cites] Biotechniques. 1994 Apr;16(4):626-8, 630-3 [8024782.001]
  • [Cites] J Virol. 1995 Feb;69(2):1093-8 [7815488.001]
  • [Cites] FEBS Lett. 1995 May 1;364(1):1-4 [7750533.001]
  • [Cites] J Biol Chem. 1996 May 3;271(18):10538-44 [8631853.001]
  • [Cites] J Virol. 1996 Jun;70(6):3706-15 [8648705.001]
  • [Cites] Microbiol Rev. 1996 Mar;60(1):103-34 [8852897.001]
  • [Cites] J Virol. 1998 Jun;72(6):4819-24 [9573247.001]
  • [Cites] J Virol. 1999 Jul;73(7):5431-7 [10364290.001]
  • [Cites] J Biol Chem. 2005 Dec 23;280(51):42106-12 [16257973.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 May 30;103(22):8360-5 [16717193.001]
  • [Cites] Mol Cell. 2006 Oct 20;24(2):165-7 [17052449.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10565-70 [18647839.001]
  • [Cites] J Virol. 2000 Jan;74(2):784-95 [10623740.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2000;64:131-70 [10697409.001]
  • [Cites] J Virol. 2000 Sep;74(18):8452-9 [10954545.001]
  • [Cites] J Virol. 2001 Feb;75(4):1834-41 [11160682.001]
  • [Cites] J Virol. 2001 Mar;75(6):2526-34 [11222675.001]
  • [Cites] J Virol. 2001 Oct;75(19):9543-8 [11533218.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14631-6 [11724937.001]
  • [Cites] J Virol. 2002 Apr;76(7):3221-31 [11884546.001]
  • [Cites] Nucleic Acids Res. 2002 Dec 1;30(23):5094-102 [12466532.001]
  • (PMID = 19062065.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA027834-28; United States / NCI NIH HHS / CA / R37 CA027834; United States / NCI NIH HHS / CA / CA 27834; United States / NCI NIH HHS / CA / CA027834-28; United States / NCI NIH HHS / CA / R01 CA027834
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Gene Products, pol; 0 / RNA, Messenger; 0 / RNA, Viral; 0 / Viral Proteins
  • [Other-IDs] NLM/ NIHMS500971; NLM/ PMC3779691
  •  go-up   go-down


10. Oh J, Chang KW, Hughes SH: Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J Virol; 2006 Jan;80(1):451-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.
  • We changed the two nucleotides (TT) between the PBS and the CA dinucleotide of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z to match the HIV-1 sequence (G) and the HIV-2 sequence (GGT), and we changed the CA dinucleotide to TC.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Feb;75(3):1132-41 [11152486.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Virol. 2002 Dec;76(24):13111-5 [12438642.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Virology. 2004 Jan 20;318(2):566-81 [14972525.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] J Virol. 1973 Dec;12(6):1226-37 [4357505.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 1977;20:131-60 [71747.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):3937-41 [6254003.001]
  • [Cites] Cell. 1980 Nov;22(2 Pt 2):379-86 [6256079.001]
  • [Cites] J Virol. 1980 Dec;36(3):692-700 [6162035.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4299-303 [6270669.001]
  • [Cites] Cell. 1985 Jan;40(1):9-17 [2981635.001]
  • [Cites] Nature. 1985 Jan 24-30;313(6000):277-84 [2578615.001]
  • [Cites] Cell. 1985 Sep;42(2):573-80 [4028161.001]
  • [Cites] J Virol. 1987 Jun;61(6):1964-71 [2437326.001]
  • [Cites] J Mol Biol. 1988 Jan 5;199(1):47-59 [3351923.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] J Mol Biol. 1989 Aug 5;208(3):445-56 [2477553.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] J Virol. 1990 Oct;64(10):4903-6 [1697909.001]
  • [Cites] J Virol. 1991 Jul;65(7):3906-10 [2041100.001]
  • [Cites] Biochemistry. 1991 Jul 23;30(29):7041-6 [1713059.001]
  • [Cites] J Virol. 1992 Jan;66(1):367-73 [1370087.001]
  • [Cites] J Virol. 1992 Aug;66(8):5092-5 [1629963.001]
  • [Cites] J Virol. 1996 Jun;70(6):3571-80 [8648691.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Mol Cell Biol. 2001 Oct;21(20):6758-67 [11564861.001]
  • (PMID = 16352569.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA primers; 0 / RNA, Small Nuclear; 0 / U5 small nuclear RNA; 63231-63-0 / RNA; 9014-25-9 / RNA, Transfer; EC 3.1.26.4 / Ribonuclease H
  • [Other-IDs] NLM/ PMC1317513
  •  go-up   go-down


11. Zhou J, McAllen JK, Tailor Y, Summers MF: High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus. J Mol Biol; 2005 Jun 24;349(5):976-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus.
  • Recently, a relatively short, 82 nucleotide region of the Rous sarcoma virus (RSV) genome, called muPsi, was shown to be sufficient to direct efficient packaging of heterologous RNAs into RSV-like particles.
  • [MeSH-major] Avian Sarcoma Viruses / chemistry. Nucleocapsid Proteins / chemistry. RNA, Viral / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15907938.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / GM08663; United States / NIGMS NIH HHS / GM / GM42561
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nucleocapsid Proteins; 0 / RNA, Viral
  •  go-up   go-down


12. Isachenko N, Dyakova N, Aushev V, Chepurnych T, Gurova K, Tatosyan A: High expression of shMDG1 gene is associated with low metastatic potential of tumor cells. Oncogene; 2006 Jan 12;25(2):317-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High expression of shMDG1 gene is associated with low metastatic potential of tumor cells.
  • To get a better understanding of this process, we compared the gene expression pattern of two isogenic cell lines, HET-SR and HET-SR1 (Rous Sarcoma Virus-transformed embryo hamster fibroblasts) with different metastatic activity using the differential display technique.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16205647.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / HSP40 Heat-Shock Proteins; 0 / Molecular Chaperones; 0 / Oligosaccharides, Branched-Chain
  •  go-up   go-down


13. Nermut MV, Mulloy B: Consideration of the three-dimensional structure of core shells (capsids) in spherical retroviruses. Micron; 2007;38(5):462-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • More recent studies by cryo-electron microscopy, X-ray crystallography and in vitro assembly of the CA domain of Human immuno deficiency virus (HIV), Murine leukemia virus (MuLV) and Rous sarcoma virus (RSV) threw new light on the organization of retroviral cores.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17223564.001).
  • [ISSN] 0968-4328
  • [Journal-full-title] Micron (Oxford, England : 1993)
  • [ISO-abbreviation] Micron
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Capsid Proteins
  •  go-up   go-down


14. Zhou J, Bean RL, Vogt VM, Summers M: Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex. J Mol Biol; 2007 Jan 12;365(2):453-67
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.
  • The Rous sarcoma virus (RSV) is an exception, in that its genome can be packaged efficiently by a relatively short, 82 nt segment of the 5'-UTR called muPsi.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Prog Nucleic Acid Res Mol Biol. 1996;54:1-34 [8768071.001]
  • [Cites] J Virol. 2000 Dec;74(24):11581-8 [11090156.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] Biochimie. 1996;78(7):639-53 [8955907.001]
  • [Cites] J Mol Biol. 1997 Feb 28;266(3):493-506 [9067606.001]
  • [Cites] EMBO J. 1997 Jun 2;16(11):3289-302 [9214644.001]
  • [Cites] J Mol Biol. 1997 Oct 17;273(1):283-98 [9367762.001]
  • [Cites] J Biol Chem. 2002 May 31;277(22):19967-75 [11896057.001]
  • [Cites] Nucleic Acids Res. 2002 Jun 15;30(12):2647-55 [12060681.001]
  • [Cites] Nucleic Acids Res. 2002 Oct 15;30(20):4371-9 [12384583.001]
  • [Cites] J Virol. 2003 Feb;77(3):2010-20 [12525635.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):427-42 [15003457.001]
  • [Cites] Nat Rev Microbiol. 2004 Jun;2(6):461-72 [15152202.001]
  • [Cites] J Virol. 2004 Aug;78(16):8486-95 [15280457.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):586-90 [15457265.001]
  • [Cites] Microbiol Rev. 1983 Dec;47(4):621-69 [6363901.001]
  • [Cites] Mol Cell Biol. 1985 Feb;5(2):281-90 [2983187.001]
  • [Cites] J Virol. 1985 May;54(2):401-7 [3989912.001]
  • [Cites] J Virol. 1986 Jul;59(1):163-7 [3012114.001]
  • [Cites] Nucleic Acids Res. 1988;16 Suppl:r175-269 [3368328.001]
  • [Cites] J Virol. 1988 Oct;62(10):3622-30 [2458484.001]
  • [Cites] J Virol. 1990 Feb;64(2):774-83 [2153242.001]
  • [Cites] Biochemistry. 1990 Jan 16;29(2):329-40 [2105740.001]
  • [Cites] Nature. 1990 Aug 16;346(6285):613-4 [1696683.001]
  • [Cites] Nature. 1990 Aug 16;346(6285):680-2 [1696688.001]
  • [Cites] J Virol. 1990 Oct;64(10):5076-92 [1697912.001]
  • [Cites] J Mol Biol. 1990 Dec 5;216(3):585-610 [2258934.001]
  • [Cites] J Virol. 1991 Jan;65(1):71-80 [1985218.001]
  • [Cites] Biochemistry. 1991 Apr 2;30(13):3280-9 [1706937.001]
  • [Cites] J Virol. 1991 Jul;65(7):3864-72 [1710292.001]
  • [Cites] Nucleic Acids Res. 1991 Dec 25;19(24):6929-34 [1662367.001]
  • [Cites] J Virol. 1992 Aug;66(8):4662-70 [1378506.001]
  • [Cites] EMBO J. 1992 Oct;11(10):3747-57 [1327749.001]
  • [Cites] Crit Rev Oncog. 1992;3(4):401-46 [1384720.001]
  • [Cites] J Virol. 1993 Jan;67(1):178-88 [8380070.001]
  • [Cites] J Biomol NMR. 1992 Nov;2(6):661-5 [1490109.001]
  • [Cites] Protein Sci. 1993 Jan;2(1):3-19 [8443588.001]
  • [Cites] J Virol. 1993 Jul;67(7):4337-49 [7685415.001]
  • [Cites] J Mol Biol. 1994 Feb 11;236(1):49-63 [8107125.001]
  • [Cites] J Mol Biol. 1994 Mar 11;236(5):1271-6 [7510342.001]
  • [Cites] Arch Virol Suppl. 1994;9:513-22 [8032280.001]
  • [Cites] Science. 1998 Jan 16;279(5349):384-8 [9430589.001]
  • [Cites] J Virol. 1998 Jul;72(7):6190-4 [9621088.001]
  • [Cites] J Virol. 1998 Oct;72(10):8073-82 [9733847.001]
  • [Cites] J Gen Virol. 1998 Dec;79 ( Pt 12):2877-82 [9880000.001]
  • [Cites] J Virol. 1999 Aug;73(8):6282-92 [10400719.001]
  • [Cites] J Virol. 1999 Nov;73(11):8926-33 [10515997.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] Retrovirology. 2004;1:22 [15317659.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):643-55 [16064056.001]
  • [Cites] Nature. 1994 Nov 3;372(6501):111-3 [7526219.001]
  • [Cites] Nucleic Acids Res. 1995 Mar 11;23(5):861-8 [7708504.001]
  • [Cites] J Mol Biol. 1995 Jul 14;250(3):333-53 [7608979.001]
  • [Cites] J Biomol NMR. 1995 Nov;6(3):277-93 [8520220.001]
  • [Cites] J Virol. 2000 Jan;74(1):456-64 [10590135.001]
  • [Cites] J Mol Biol. 2000 Aug 11;301(2):491-511 [10926523.001]
  • [Cites] J Virol. 2000 Oct;74(19):9167-74 [10982363.001]
  • [Cites] J Mol Biol. 2000 Nov 17;304(1):35-42 [11071808.001]
  • [Cites] Science. 1996 Sep 20;273(5282):1678-85 [8781224.001]
  • (PMID = 17070546.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] ENG
  • [Databank-accession-numbers] PDB/ 2IHX
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NIGMS NIH HHS / GM / R01 GM042561; United States / NCI NIH HHS / CA / CA20081; United States / NIGMS NIH HHS / GM / GM42561
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nucleocapsid Proteins; 0 / RNA, Viral; 0 / Solutions
  • [Other-IDs] NLM/ NIHMS15191; NLM/ PMC1764217
  •  go-up   go-down


15. Jaskolski M, Alexandratos JN, Bujacz G, Wlodawer A: Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J; 2009 Jun;276(11):2926-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although the Protein Data Bank contains a number of NMR structures of the N-terminal and C-terminal domains of HIV-1 and HIV-2, simian immunodeficiency virus and avian sarcoma virus IN, as well as X-ray structures of the core domain of HIV-1, avian sarcoma virus and foamy virus IN, plus several models of two-domain constructs, no structure of the complete molecule of retroviral IN has been solved to date.

  • Genetic Alliance. consumer health - AIDS-HIV.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Annu Rev Biochem. 1993;62:543-85 [8352596.001]
  • [Cites] J Virol. 1994 Apr;68(4):2215-23 [8139006.001]
  • [Cites] Annu Rev Biochem. 1994;63:133-73 [7526778.001]
  • [Cites] Science. 1994 Dec 23;266(5193):1981-6 [7801124.001]
  • [Cites] Virology. 1995 Jan 10;206(1):448-56 [7831800.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6057-61 [7597080.001]
  • [Cites] Biochemistry. 1995 Aug 8;34(31):9826-33 [7632683.001]
  • [Cites] Nat Struct Biol. 1995 Sep;2(9):807-10 [7552753.001]
  • [Cites] J Mol Biol. 1995 Oct 20;253(2):333-46 [7563093.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60 [8524782.001]
  • [Cites] Structure. 1996 Jan 15;4(1):89-96 [8805516.001]
  • [Cites] Eur J Biochem. 1996 Sep 15;240(3):765-73 [8856082.001]
  • [Cites] FEBS Lett. 1996 Dec 2;398(2-3):175-8 [8977101.001]
  • [Cites] Science. 1997 Apr 4;276(5309):49-51 [9122709.001]
  • [Cites] J Biol Chem. 1997 Jul 18;272(29):18161-8 [9218451.001]
  • [Cites] Nat Struct Biol. 1997 Jul;4(7):567-77 [9228950.001]
  • [Cites] Biochemistry. 1997 Sep 2;36(35):10655-65 [9271496.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):739-46 [9368756.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4831-6 [9560188.001]
  • [Cites] J Virol. 1998 Jun;72(6):4841-8 [9573250.001]
  • [Cites] Biochemistry. 1998 May 12;37(19):6667-78 [9578550.001]
  • [Cites] Annu Rev Biophys Biomol Struct. 1998;27:249-84 [9646869.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9150-4 [9689049.001]
  • [Cites] J Mol Biol. 1998 Sep 18;282(2):359-68 [9735293.001]
  • [Cites] Annu Rev Biochem. 1998;67:1-25 [9759480.001]
  • [Cites] J Biol Chem. 1998 Dec 4;273(49):32685-9 [9830010.001]
  • [Cites] Protein Sci. 1998 Dec;7(12):2669-74 [9865962.001]
  • [Cites] Adv Virus Res. 1999;52:319-33 [10384240.001]
  • [Cites] Adv Virus Res. 1999;52:351-69 [10384242.001]
  • [Cites] Biochemistry. 1999 Jul 13;38(28):8892-8 [10413462.001]
  • [Cites] Proteins. 1999 Sep 1;36(4):556-64 [10450096.001]
  • [Cites] Biochemistry. 1999 Oct 12;38(41):13512-22 [10521258.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48883-92 [15371438.001]
  • [Cites] Bioorg Med Chem. 2004 Dec 15;12(24):6371-81 [15556755.001]
  • [Cites] Curr Opin Struct Biol. 2004 Dec;14(6):716-30 [15582396.001]
  • [Cites] J Biol Chem. 2003 Jan 3;278(1):372-81 [12407101.001]
  • [Cites] Trends Pharmacol Sci. 2005 Jan;26(1):4-7 [15629197.001]
  • [Cites] Cell. 2005 Jul 1;121(7):1005-16 [15989951.001]
  • [Cites] Nat Struct Mol Biol. 2005 Oct;12(10):935-6 [16155580.001]
  • [Cites] Adv Genet. 2005;55:147-81 [16291214.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17308-13 [16260736.001]
  • [Cites] J Biol Chem. 2006 Feb 17;281(7):4173-82 [16298997.001]
  • [Cites] Trends Biochem Sci. 2006 Feb;31(2):98-105 [16403635.001]
  • [Cites] Nucleic Acids Res. 2006;34(5):1653-65 [16549878.001]
  • [Cites] Mol Cell. 2006 Apr 7;22(1):5-13 [16600865.001]
  • [Cites] EMBO J. 2006 May 3;25(9):1924-33 [16601679.001]
  • [Cites] Curr Opin Microbiol. 2006 Aug;9(4):437-42 [16829161.001]
  • [Cites] Antiviral Res. 2006 Sep;71(2-3):260-7 [16872687.001]
  • [Cites] Curr Med Chem. 2006;13(20):2429-41 [16918363.001]
  • [Cites] J Mol Biol. 2007 Feb 9;366(1):286-94 [17157316.001]
  • [Cites] Nucleic Acids Res. 2007;35(3):975-87 [17259219.001]
  • [Cites] Genes Funct. 1997 Dec;1(5-6):289-307 [17366700.001]
  • [Cites] Retrovirology. 2007;4:21 [17374162.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 May 15;104(20):8316-21 [17488811.001]
  • [Cites] Adv Pharmacol. 2007;55:261-98 [17586318.001]
  • [Cites] Rev Med Virol. 2007 Jul-Aug;17(4):277-95 [17503547.001]
  • [Cites] Curr Med Chem. 2007;14(26):2734-48 [18045120.001]
  • [Cites] PLoS Pathog. 2008 Mar;4(3):e1000046 [18369482.001]
  • [Cites] Virus Res. 2008 Jun;134(1-2):186-202 [18294720.001]
  • [Cites] Expert Opin Emerg Drugs. 2008 Jun;13(2):213-25 [18537517.001]
  • [Cites] J Mol Biol. 2008 Jul 11;380(3):504-19 [18565342.001]
  • [Cites] Curr Opin Drug Discov Devel. 2008 Jul;11(4):471-9 [18600564.001]
  • [Cites] J Med Chem. 2008 Aug 14;51(15):4744-50 [18646746.001]
  • [Cites] Biochemistry. 2008 Sep 9;47(36):9345-54 [18702518.001]
  • [Cites] Retrovirology. 2008;5:74 [18687142.001]
  • [Cites] J Med Chem. 2008 Sep 25;51(18):5843-55 [18763751.001]
  • [Cites] AIDS Rev. 2008 Jul-Sep;10(3):172-89 [18820719.001]
  • [Cites] Methods Mol Biol. 2009;485:135-49 [19020823.001]
  • [Cites] PLoS One. 2009;4(1):e4081 [19119323.001]
  • [Cites] J Mol Biol. 2009 Jan 16;385(2):568-79 [19014951.001]
  • [Cites] PLoS Pathog. 2009 Jan;5(1):e1000259 [19132083.001]
  • [Cites] J Mol Biol. 2009 Jan 23;385(3):693-713 [19022262.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(1):243-55 [19036793.001]
  • [Cites] J Med Chem. 2009 Jan 22;52(2):569-73 [19105658.001]
  • [Cites] FEBS J. 2005 Jan;272(1):203-16 [15634344.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13040-3 [10557269.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Dec;63(4):836-43, table of contents [10585967.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):521-33 [10669606.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):535-48 [10669607.001]
  • [Cites] Science. 2000 Jul 7;289(5476):77-85 [10884228.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8233-8 [10890912.001]
  • [Cites] Biochemistry. 2000 Aug 8;39(31):9275-84 [10924120.001]
  • [Cites] Biochemistry. 2000 Aug 8;39(31):9285-94 [10924121.001]
  • [Cites] J Biomol NMR. 2000 Oct;18(2):119-28 [11101216.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):536-44 [11264582.001]
  • [Cites] EMBO J. 2001 Jul 2;20(13):3565-76 [11432843.001]
  • [Cites] Biochemistry. 2001 Nov 20;40(46):13840-8 [11705373.001]
  • [Cites] J Mol Biol. 2001 Dec 7;314(4):863-71 [11734003.001]
  • [Cites] EMBO J. 2001 Dec 17;20(24):7333-43 [11743009.001]
  • [Cites] J Am Chem Soc. 2001 Dec 19;123(50):12708-9 [11741448.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):134-7 [11756686.001]
  • [Cites] Annu Rev Med. 2002;53:595-614 [11818491.001]
  • [Cites] Nat Struct Biol. 2002 Apr;9(4):278-81 [11896402.001]
  • [Cites] Proteins. 2002 Dec 1;49(4):429-31 [12402352.001]
  • [Cites] J Biol Chem. 2003 Jan 10;278(2):1323-7 [12446721.001]
  • [Cites] Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7 [12643937.001]
  • [Cites] J Virol. 2003 Apr;77(8):5030-6 [12663813.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):33528-39 [12796494.001]
  • [Cites] J Gene Med. 2004 Feb;6 Suppl 1:S95-104 [14978754.001]
  • [Cites] J Med Chem. 2004 Apr 8;47(8):1879-81 [15055986.001]
  • [Cites] Curr Top Med Chem. 2004;4(9):965-77 [15134551.001]
  • [Cites] Virology. 1978 Aug;89(1):119-32 [210568.001]
  • [Cites] J Virol. 1988 Feb;62(2):528-33 [2447290.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6498-502 [8341661.001]
  • (PMID = 19490099.001).
  • [ISSN] 1742-4658
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 BC010348-08
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Viral Proteins; EC 2.7.7.- / Integrases
  • [Number-of-references] 108
  • [Other-IDs] NLM/ NIHMS140284; NLM/ PMC2747025
  •  go-up   go-down


16. Yeo MG, Song WK: v-Crk regulates membrane dynamics and Rac activation. Cell Adh Migr; 2008 Jul-Sep;2(3):174-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We recently used CAS (Crk-associated substrate, 130CAS)-deficient mouse embryo fibroblasts (MEFs) to examined contribution made to v-Crk to that process via its interaction with Rac1. v-Crk, the oncogene product of avian sarcoma virus CT10, directly affects membrane ruffle formation and is associated with Rac1 activation, even in the absence of CAS, a major substrate for Crk.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Cell Biol. 2002 Mar;4(3):232-9 [11862216.001]
  • [Cites] Mol Cells. 2008 Feb 29;25(1):131-7 [18319625.001]
  • [Cites] J Biol Chem. 2002 Jul 26;277(30):27265-72 [12011056.001]
  • [Cites] Mol Biol Cell. 2002 Sep;13(9):3203-17 [12221126.001]
  • [Cites] Curr Biol. 2003 Mar 18;13(6):R236-8 [12646151.001]
  • [Cites] Science. 2003 Dec 5;302(5651):1704-9 [14657486.001]
  • [Cites] Nature. 1988 Mar 17;332(6161):272-5 [2450282.001]
  • [Cites] Science. 1990 Jun 22;248(4962):1537-9 [1694307.001]
  • [Cites] EMBO J. 1994 Aug 15;13(16):3748-56 [8070403.001]
  • [Cites] Nature. 1995 Oct 12;377(6549):539-44 [7566154.001]
  • [Cites] Cell. 1996 Feb 9;84(3):359-69 [8608589.001]
  • [Cites] Mol Cell Biol. 1996 Jun;16(6):3169-78 [8649427.001]
  • [Cites] J Cell Sci. 1997 Feb;110 ( Pt 3):389-99 [9057091.001]
  • [Cites] J Cell Sci. 1997 Mar;110 ( Pt 6):707-20 [9099945.001]
  • [Cites] J Cell Biol. 1998 Feb 23;140(4):961-72 [9472046.001]
  • [Cites] Mol Biol Cell. 1998 Jul;9(7):1863-71 [9658176.001]
  • [Cites] Nat Genet. 1998 Aug;19(4):361-5 [9697697.001]
  • [Cites] EMBO J. 1999 May 4;18(9):2459-71 [10228160.001]
  • [Cites] Mol Cell Biol. 2006 Jun;26(12):4399-409 [16738308.001]
  • [Cites] Mol Cell Biol. 2006 Aug;26(16):6272-82 [16880535.001]
  • [Cites] Mol Biol Cell. 2007 Feb;18(2):678-87 [17182853.001]
  • [Cites] J Cell Biol. 2007 Dec 17;179(6):1275-87 [18070912.001]
  • [Cites] J Cell Physiol. 2008 Mar;214(3):604-13 [17786957.001]
  • [Cites] Nat Cell Biol. 2002 Apr;4(4):E97-100 [11944043.001]
  • (PMID = 19262107.001).
  • [ISSN] 1933-6926
  • [Journal-full-title] Cell adhesion & migration
  • [ISO-abbreviation] Cell Adh Migr
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oncogene Protein v-crk; EC 3.6.5.2 / rac GTP-Binding Proteins
  • [Other-IDs] NLM/ PMC2634094
  •  go-up   go-down


17. Zhang HM, Bacon LD, Cheng HH, Hunt HD: Development and validation of a PCR-RFLP assay to evaluate TVB haplotypes coding receptors for subgroup B and subgroup E avian leukosis viruses in White Leghorns. Avian Pathol; 2005 Aug;34(4):324-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development and validation of a PCR-RFLP assay to evaluate TVB haplotypes coding receptors for subgroup B and subgroup E avian leukosis viruses in White Leghorns.
  • The cellular receptor of subgroup B avian leukosis virus (ALVB) is encoded by a gene at the tumour virus B (TVB) locus.
  • TVB alleles encode specific receptors permitting infection by exogenous ALVB or avian leukosis virus subgroup D (ALVD) as well as endogenous avian leukosis virus subgroup E (ALVE), and thus susceptibility is dominant to resistance.
  • Chickens from parents heterozygous for different TVB alleles were challenged with Rous sarcoma viruses of subgroup ALVB and ALVE to induce wing-web tumours.
  • [MeSH-major] Avian Leukosis Virus. Avian Proteins / genetics. Chickens / genetics. Polymerase Chain Reaction / methods. Receptors, Virus / genetics
  • [MeSH-minor] Alleles. Animals. Avian Sarcoma Viruses. Haplotypes. Polymorphism, Restriction Fragment Length. Sarcoma, Avian / virology

  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16147569.001).
  • [ISSN] 0307-9457
  • [Journal-full-title] Avian pathology : journal of the W.V.P.A
  • [ISO-abbreviation] Avian Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Receptors, Virus
  •  go-up   go-down


18. Wiedmann MW, Caca K: Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets; 2005 May;5(3):171-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are critical regulators of tumor angiogenesis.
  • Other promising new drugs currently under preclinical and clinical evaluation, are VEGFR2 inhibitor PTK787/ZK 222584, thalidomide, farnesyl transferase inhibitor R115777 (tipifarnib, Zarnestra(TM)), matrix metalloproteinase inhibitors, proteasome inhibitor bortezomib (Velcade(TM)), mammalian target of rapamycin (mTOR) inhibitors, cyclooxygenase-2 (COX-2) inhibitors, platelet derived growth factor receptor (PDGF-R) inhibitors, protein kinase C (PKC) inhibitors, mitogen-activated protein kinase kinase (MEK) 1/2 inhibitors, Rous sarcoma virus transforming oncogene (SRC) kinase inhibitors, histondeacetylase (HDAC) inhibitors, small hypoxia-inducible factor (HIF) inhibitors, aurora kinase inhibitors, hedgehog inhibitors, and TGF-beta signalling inhibitors.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15892618.001).
  • [ISSN] 1568-0096
  • [Journal-full-title] Current cancer drug targets
  • [ISO-abbreviation] Curr Cancer Drug Targets
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 2.7.10.1 / Receptors, Vascular Endothelial Growth Factor
  • [Number-of-references] 102
  •  go-up   go-down


19. Portsmouth D, Deitermann D, Salmons B, Günzburg WH, Renner M: Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors. J Virol; 2008 Feb;82(3):1610-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors.
  • Rous sarcoma virus (RSV) can be used for the simple generation of high-titer replication-competent retroviral (RCR) vectors.
  • [MeSH-major] Genetic Vectors. Genomic Instability. RNA Splice Sites. Recombinant Proteins / biosynthesis. Rous sarcoma virus / genetics. Transgenes

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Biochem Sci. 2000 Mar;25(3):106-10 [10694877.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Exp Med. 1977 Dec 1;146(6):1735-47 [200700.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Dec;75(12):5812-6 [215998.001]
  • [Cites] J Virol. 1979 Nov;32(2):546-56 [228078.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Virology. 1984 Jul 15;136(1):89-99 [6330999.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1560-72 [2174810.001]
  • [Cites] J Virol. 1991 Jul;65(7):3728-37 [2041092.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Mol Biotechnol. 1997 Jun;7(3):289-98 [9219242.001]
  • [Cites] Gene. 1997 Nov 20;202(1-2):23-9 [9427541.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Sep;76(9):4479-83 [92031.001]
  • (PMID = 18057258.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA Splice Sites; 0 / Recombinant Proteins
  • [Other-IDs] NLM/ PMC2224446
  •  go-up   go-down


20. Minemura M, Shimizu Y, Hirano K, Nakayama Y, Tokimitsu Y, Tajiri K, Yamada K, Xue F, Takahara T, Watanabe A, Sugiyama T: Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinoma. Oncol Rep; 2005 Aug;14(2):495-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Functional analysis of the mutants of the X gene was performed on the long terminal repeat of the Rous sarcoma virus in a transient transfection assay.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / genetics. Base Sequence. Carcinoma, Hepatocellular / genetics. Carcinoma, Hepatocellular / pathology. Cell Line, Tumor. Cell-Free System. Genetic Vectors / genetics. Humans. Molecular Sequence Data. Protein Biosynthesis / genetics. Rabbits. Reticulocytes / metabolism. Sequence Homology, Nucleic Acid. Transcription, Genetic / genetics. Transfection

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012736.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Trans-Activators; 0 / hepatitis B virus X protein
  •  go-up   go-down


21. Amberg SM, Netter RC, Simmons G, Bates P: Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide. J Virol; 2006 Jan;80(1):353-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Resistance to an HR2-based peptide inhibitor of a model retrovirus, subgroup A of the Avian Sarcoma and Leukosis Virus genus (ASLV-A), was studied by examining mutants derived by viral passage in the presence of inhibitor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2002 Jan;76(1):178-84 [11739683.001]
  • [Cites] J Virol. 2005 Apr;79(8):4991-9 [15795284.001]
  • [Cites] J Virol. 2002 Mar;76(6):2595-605 [11861825.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 [12019106.001]
  • [Cites] Trends Cell Biol. 2002 Jun;12(6):273-80 [12074887.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] BMC Microbiol. 2001;1:1 [11208257.001]
  • [Cites] J Virol. 2002 Nov;76(22):11186-98 [12388678.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54 [12444251.001]
  • [Cites] AIDS. 2003 Feb 14;17(3):291-300 [12556682.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] J Virol. 2003 Mar;77(5):3281-90 [12584351.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] J Virol. 2003 Jun;77(12):6709-19 [12767991.001]
  • [Cites] Biochim Biophys Acta. 2003 Jul 11;1614(1):116-21 [12873772.001]
  • [Cites] J Virol. 2003 Aug;77(16):8801-11 [12885899.001]
  • [Cites] Oncogene. 2003 Sep 11;22(39):7931-41 [12970741.001]
  • [Cites] J Gen Virol. 2003 Dec;84(Pt 12):3233-8 [14645905.001]
  • [Cites] J Gen Virol. 2004 Mar;85(Pt 3):647-52 [14993650.001]
  • [Cites] Nat Rev Drug Discov. 2004 Mar;3(3):215-25 [15031735.001]
  • [Cites] Lancet. 2004 Mar 20;363(9413):938-47 [15043961.001]
  • [Cites] J Virol. 2004 May;78(9):4628-37 [15078945.001]
  • [Cites] J Virol. 2004 May;78(10):5476-85 [15113926.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60 [15150417.001]
  • [Cites] J Virol. 2004 Jul;78(14):7582-9 [15220433.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] J Antimicrob Chemother. 2004 Aug;54(2):333-40 [15231762.001]
  • [Cites] Virology. 1986 May;151(1):139-45 [3008429.001]
  • [Cites] Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 [2631796.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10537-41 [1438243.001]
  • [Cites] FEBS Lett. 1992 Jul 6;305(3):181-4 [1299611.001]
  • [Cites] Nature. 1993 Sep 9;365(6442):113 [8371754.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1994 Sep;68(9):5623-8 [8057442.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 [7937889.001]
  • [Cites] Nucleic Acids Res. 1995 Feb 25;23(4):628-33 [7899083.001]
  • [Cites] J Virol. 2000 Sep;74(18):8358-67 [10954535.001]
  • [Cites] J Virol. 2000 Oct;74(20):9738-41 [11000247.001]
  • [Cites] J Virol. 2000 Nov;74(21):10194-201 [11024148.001]
  • [Cites] J Virol. 2001 Mar;75(5):2041-50 [11160708.001]
  • [Cites] J Virol. 2001 Apr;75(8):3568-80 [11264346.001]
  • [Cites] J Virol. 2001 Apr;75(8):3903-15 [11264379.001]
  • [Cites] Curr Opin Microbiol. 2001 Aug;4(4):450-5 [11495810.001]
  • [Cites] J Virol. 2001 Sep;75(18):8605-14 [11507206.001]
  • [Cites] J Virol. 1995 Dec;69(12):7410-5 [7494245.001]
  • [Cites] EMBO J. 1995 Nov 15;14(22):5524-31 [8521809.001]
  • [Cites] J Virol. 1996 Mar;70(3):1564-9 [8627675.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91 [8700906.001]
  • [Cites] J Virol. 1996 Nov;70(11):7510-6 [8892869.001]
  • [Cites] J Virol. 1997 Feb;71(2):1453-65 [8995671.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14306-13 [9405608.001]
  • [Cites] J Virol. 1998 Feb;72(2):986-93 [9444991.001]
  • [Cites] J Virol. 1998 Apr;72(4):3155-60 [9525641.001]
  • [Cites] J Virol. 1998 Apr;72(4):3259-67 [9525653.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8467-72 [9671701.001]
  • [Cites] Mol Cell. 1998 Nov;2(5):605-16 [9844633.001]
  • [Cites] J Virol. 1999 Apr;73(4):3054-61 [10074155.001]
  • [Cites] J Virol. 1999 Apr;73(4):3087-94 [10074159.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7 [10077567.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6359-64 [10339592.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] J Virol. 2002 Jan;76(2):644-55 [11752155.001]
  • (PMID = 16352560.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01-CA76256; United States / NIAID NIH HHS / AI / F32-AI050341; United States / NIAID NIH HHS / AI / R01 AI043455; United States / NIAID NIH HHS / AI / F32 AI050341; United States / NIGMS NIH HHS / GM / T32 GM007229; United States / NIAID NIH HHS / AI / R01-AI43455; United States / NCI NIH HHS / CA / R01 CA076256; United States / NIGMS NIH HHS / GM / T32-GM07229
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Peptides; 0 / Viral Envelope Proteins; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC1317511
  •  go-up   go-down


22. Homsi J, Cubitt C, Daud A: The Src signaling pathway: a potential target in melanoma and other malignancies. Expert Opin Ther Targets; 2007 Jan;11(1):91-100
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although Src was the first oncogene to be discovered as the transforming protein of the Rous sarcoma virus almost three decades ago, the role of Src and the Src family kinases in human oncogenesis is still not completely understood.
  • Recent studies have shown that Src regulates cell adhesion, invasiveness and motility in cancer cells and in tumor vasculature, rather than directly influencing cell replication.
  • Studies are currently underway with novel Src inhibitors in melanoma and in other tumor types.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17150037.001).
  • [ISSN] 1744-7631
  • [Journal-full-title] Expert opinion on therapeutic targets
  • [ISO-abbreviation] Expert Opin. Ther. Targets
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Protein Kinase Inhibitors; EC 2.7.10.2 / src-Family Kinases
  • [Number-of-references] 99
  •  go-up   go-down


23. Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R, Baum C, Bohne J: Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther; 2006 Nov;13(21):1524-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When using the promoter of Rous sarcoma virus or a tetracycline-inducible promoter to generate full-length transcripts, we obtained a strong enhancement in titer (up to 4 x 10(7) transducing units per ml of unconcentrated supernatant).

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16763662.001).
  • [ISSN] 0969-7128
  • [Journal-full-title] Gene therapy
  • [ISO-abbreviation] Gene Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34
  •  go-up   go-down


24. Medina G, Pincetic A, Ehrlich LS, Zhang Y, Tang Y, Leis J, Carter CA: Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. Virology; 2008 Jul 20;377(1):30-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Late (L) domain of the avian sarcoma virus (ASV) Gag protein binds Nedd4 ubiquitin ligase E3 family members and is the determinant of efficient virus release in avian and mammalian cells.
  • The evidence that Tsg101 and Nedd4 direct release by different pathways is: (i) Release of the virus-like particles (VLPs) assembled from Gag in DF-1, an avian cell line, was resistant to dominant-negative interference by a Tsg101 mutant previously shown to inhibit release of both HIV and Mo-MLV. (ii) Release of VLPs from DF-1 cells was resistant to siRNA-mediated depletion of the endogenous pool of Tsg101 in these cells. (iii) VLPs assembled from wild-type ASV Gag exhibited highly efficient release from endosome-like membrane domains enriched in the tetraspanin protein CD63 or a fluorescent analogue of the phospholipid phosphatidylethanolamine.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Apr;74(7):3046-57 [10708419.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] AIDS. 2001;15 Suppl 5:S13-20 [11816161.001]
  • [Cites] J Cell Biol. 2002 Apr 1;157(1):91-101 [11916981.001]
  • [Cites] J Virol. 2003 Jan;77(1):470-80 [12477852.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7626-31 [12802020.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] Traffic. 2003 Dec;4(12):902-10 [14617353.001]
  • [Cites] J Cell Biol. 2004 Apr12;165(1):135-44 [15078904.001]
  • [Cites] Genes Dev. 2004 Jul 15;18(14):1737-52 [15256501.001]
  • [Cites] Eur J Cell Biol. 1990 Oct;53(1):173-84 [2076704.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] Mol Biol Cell. 1992 Dec;3(12):1389-402 [1493335.001]
  • [Cites] J Virol. 1994 Apr;68(4):2556-69 [8139035.001]
  • [Cites] J Virol. 1994 May;68(5):3232-42 [8151785.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1996 Dec;70(12):8540-8 [8970978.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] J Cell Sci. 1997 Aug;110 ( Pt 16):1867-77 [9296387.001]
  • [Cites] J Virol. 1998 Apr;72(4):2723-32 [9525590.001]
  • [Cites] EMBO J. 1998 Jun 1;17(11):2982-93 [9606181.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Oct;73(10):8527-40 [10482606.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] J Virol. 2005 Mar;79(6):3775-86 [15731271.001]
  • [Cites] Biochem J. 2005 Apr 1;387(Pt 1):17-26 [15511219.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] Virology. 2006 Jan 5;344(1):55-63 [16364736.001]
  • [Cites] J Cell Biol. 2006 Jun 5;173(5):795-807 [16735575.001]
  • [Cites] Mol Biol Cell. 2007 Apr;18(4):1129-42 [17229889.001]
  • [Cites] J Virol. 2008 May;82(10):4884-97 [18321968.001]
  • [Cites] J Virol. 2008 May;82(10):4898-907 [18321969.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Cell. 2001 Jul 27;106(2):145-55 [11511343.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1619-24 [11172000.001]
  • (PMID = 18555885.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R56 AI054143-01A2; United States / NIAID NIH HHS / AI / R56 AI068463-01A1; United States / NIAID NIH HHS / AI / T32 AI060523; United States / NIAID NIH HHS / AI / AI054143-01A2; United States / NIAID NIH HHS / AI / R01 AI068463; United States / NIAID NIH HHS / AI / AI068463-01A2; United States / NCI NIH HHS / CA / 5T32 CA-09176; United States / NIAID NIH HHS / AI / R01 AI068463-01A2; United States / NIAID NIH HHS / AI / AI054143; United States / NIAID NIH HHS / AI / AI068463; United States / NIAID NIH HHS / AI / AI068463-01A1; United States / NCI NIH HHS / CA / T32 CA009176; United States / NIAID NIH HHS / AI / R56 AI068463; United States / NIAID NIH HHS / AI / R56 AI054143
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gene Products, gag; 0 / Transcription Factors; 0 / Tsg101 protein; EC 6.3.2.19 / Nedd4 ubiquitin protein ligases; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  • [Other-IDs] NLM/ NIHMS57248; NLM/ PMC2528022
  •  go-up   go-down


25. Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC: RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J Mol Biol; 2008 Feb 29;376(4):1168-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We used cryo-electron tomography to visualize Rous sarcoma virus, the prototypic alpharetrovirus.
  • We find that Rous sarcoma virus virions, like the human immunodeficiency virus, contain unassembled CA subunits and that the fraction of CA that is assembled correlates with core type; angular cores incorporate approximately 80% of the available subunits, and open-ended tubes, approximately 30%.
  • [MeSH-major] Capsid / chemistry. Polymers / chemistry. Rous sarcoma virus / chemistry. Viral Envelope Proteins / chemistry

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Oct;75(19):9357-66 [11533199.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] J Virol. 2003 Dec;77(23):12592-602 [14610182.001]
  • [Cites] Science. 2003 Nov 21;302(5649):1396-8 [14631040.001]
  • [Cites] J Struct Biol. 2003 Oct-Nov;144(1-2):114-22 [14643214.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7 [14668432.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] J Virol. 2004 Mar;78(5):2606-8 [14963166.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] Virology. 1965 Aug;26(4):567-76 [5833315.001]
  • [Cites] Mol Gen Genet. 1968 May 17;101(4):333-45 [5684818.001]
  • [Cites] J Mol Biol. 1970 May 28;50(1):35-58 [4196078.001]
  • [Cites] J Supramol Struct. 1974;2(2-4):253-75 [4612249.001]
  • [Cites] J Mol Biol. 1976 Apr 15;102(3):373-400 [775106.001]
  • [Cites] AIDS Res Hum Retroviruses. 1992 Jan;8(1):1-7 [1736937.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] Nat Struct Biol. 1996 Sep;3(9):763-70 [8784350.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] J Struct Biol. 1999 Sep;127(2):169-76 [10527906.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2772-7 [15699328.001]
  • [Cites] Curr Opin Struct Biol. 2005 Apr;15(2):227-36 [15837183.001]
  • [Cites] J Virol. 2005 Jun;79(11):6577-87 [15890896.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 17;102(20):7163-8 [15878991.001]
  • [Cites] Annu Rev Biochem. 2005;74:833-65 [15952904.001]
  • [Cites] J Struct Biol. 2005 Aug;151(2):117-29 [15964766.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):643-55 [16064056.001]
  • [Cites] J Struct Biol. 2005 Oct;152(1):36-51 [16182563.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7 [17146053.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • (PMID = 18206161.001).
  • [ISSN] 1089-8638
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 AR027002-29; United States / NCI NIH HHS / CA / R01 CA100322; United States / Intramural NIH HHS / / Z99 AR999999; United States / NCI NIH HHS / CA / CA100322; United States / NCI NIH HHS / CA / R01 CA100322-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / Gene Products, gag; 0 / Polymers; 0 / Protein Subunits; 0 / Viral Envelope Proteins
  • [Other-IDs] NLM/ NIHMS41519; NLM/ PMC2268030
  •  go-up   go-down


26. Boulos S, Meloni BP, Arthur PG, Bojarski C, Knuckey NW: Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures. Brain Res; 2006 Aug 2;1102(1):27-38
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to investigate protein function in rat primary cortical neuronal cultures, we modified an adenoviral vector expression system and assessed the strength and specificity of the cytomegalovirus (CMV), rous sarcoma virus (RSV), and rat and human synapsin 1 (SYN1) promoters to drive DsRed-X expression.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Cytomegalovirus / genetics. Genetic Vectors / physiology. Hepatitis B Virus, Woodchuck / genetics. Neurons / metabolism. Synapsins / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CUMENE HYDROPEROXIDE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16806110.001).
  • [ISSN] 0006-8993
  • [Journal-full-title] Brain research
  • [ISO-abbreviation] Brain Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzene Derivatives; 0 / Synapsins; 147336-22-9 / Green Fluorescent Proteins; PG7JD54X4I / cumene hydroperoxide
  •  go-up   go-down


27. Konsavage WM Jr, Sudol M, Katzman M: Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase. Virology; 2008 Sep 30;379(2):223-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have now made several mutations designed to alter the length or flexibility of a mobile loop within this 35-amino-acid spacer region in full-length Rous sarcoma virus integrase.
  • [MeSH-major] Integrases / chemistry. Integrases / metabolism. Rous sarcoma virus / enzymology

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18687451.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / p31 integrase protein, Human immunodeficiency virus 1; EC 2.7.7.- / HIV Integrase; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  •  go-up   go-down


28. Lee SH, Gupta MK, Han DW, Han SY, Uhm SJ, Kim T, Lee HT: Development of transgenic chickens expressing human parathormone under the control of a ubiquitous promoter by using a retrovirus vector system. Poult Sci; 2007 Oct;86(10):2221-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, by using a robust replication-defective Moloney murine leukemia virus-based retrovirus vector encapsidated with vesicular stomatitis virus G glycoprotein, we generated transgenic chickens expressing hPTH under the control of a ubiquitous Rous sarcoma virus promoter.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17878453.001).
  • [ISSN] 0032-5791
  • [Journal-full-title] Poultry science
  • [ISO-abbreviation] Poult. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Parathyroid Hormone
  •  go-up   go-down


29. Lee EG, Linial ML: Deletion of a Cys-His motif from the Alpharetrovirus nucleocapsid domain reveals late domain mutant-like budding defects. Virology; 2006 Mar 30;347(1):226-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Rous sarcoma virus (RSV) Gag polyprotein is the only protein required for virus assembly and release.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Nucleocapsid Proteins / genetics. Retroviridae Proteins / genetics

  • COS Scholar Universe. author profiles.
  • SciCrunch. The Antibody Registry: Reagent: Antibodies .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16406458.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA18282
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Nucleocapsid Proteins; 0 / Retroviridae Proteins
  •  go-up   go-down


30. Dong YF, Soung do Y, Schwarz EM, O'Keefe RJ, Drissi H: Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol; 2006 Jul;208(1):77-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Replication competent avian sarcoma (RCAS) viral over-expression of Wnt8c and Wnt9a, upregulated type X collagen (col10a1) and Runx2 mRNA expression thereby inducing chondrocyte hypertrophy.
  • [MeSH-minor] Alkaline Phosphatase / analysis. Alkaline Phosphatase / genetics. Alkaline Phosphatase / physiology. Animals. Avian Sarcoma Viruses / genetics. Blotting, Western. Bone Morphogenetic Proteins / analysis. Bone Morphogenetic Proteins / genetics. Bone Morphogenetic Proteins / physiology. Cells, Cultured. Chick Embryo. Collagen Type II / analysis. Collagen Type II / genetics. Collagen Type II / physiology. Collagen Type X / genetics. Collagen Type X / physiology. Electrophoretic Mobility Shift Assay. High Mobility Group Proteins / analysis. High Mobility Group Proteins / genetics. High Mobility Group Proteins / physiology. Hypertrophy / pathology. Hypertrophy / physiopathology. Mutation. Promoter Regions, Genetic / genetics. Promoter Regions, Genetic / physiology. RNA, Messenger / analysis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction. SOX9 Transcription Factor. Signal Transduction / genetics. Signal Transduction / physiology. TCF Transcription Factors / analysis. TCF Transcription Factors / genetics. TCF Transcription Factors / physiology. Transcription Factors / analysis. Transcription Factors / genetics. Transcription Factors / physiology. Transfection. Transforming Growth Factor beta / analysis. Transforming Growth Factor beta / physiology. beta Catenin / analysis. beta Catenin / physiology

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16575901.001).
  • [ISSN] 0021-9541
  • [Journal-full-title] Journal of cellular physiology
  • [ISO-abbreviation] J. Cell. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Morphogenetic Proteins; 0 / Collagen Type II; 0 / Collagen Type X; 0 / Core Binding Factor Alpha 1 Subunit; 0 / High Mobility Group Proteins; 0 / RNA, Messenger; 0 / SOX9 Transcription Factor; 0 / TCF Transcription Factors; 0 / Transcription Factors; 0 / Transforming Growth Factor beta; 0 / Wnt Proteins; 0 / beta Catenin; EC 3.1.3.1 / Alkaline Phosphatase
  •  go-up   go-down


31. Phillips JM, Murray PS, Murray D, Vogt VM: A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice. EMBO J; 2008 May 7;27(9):1411-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the Rous sarcoma virus (RSV) Gag protein, the 25 amino-acid residues of the p10 domain immediately upstream of the CA domain are essential for immature particle formation.
  • [MeSH-major] Gene Products, gag / chemistry. Gene Products, gag / metabolism. Rous sarcoma virus / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] Protein Eng. 1998 Sep;11(9):739-47 [9796821.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):499-520 [10860755.001]
  • [Cites] Bioinformatics. 2000 Apr;16(4):404-5 [10869041.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] J Mol Biol. 1999 Feb 12;286(1):83-93 [9931251.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Virol. 2006 Jul;80(14):7089-99 [16809314.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] Virology. 2007 Apr 10;360(2):388-97 [17156810.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] J Virol. 2007 Oct;81(19):10718-28 [17634229.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Virol. 2001 May;75(10):4761-70 [11312348.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] Proteins. 2002 May 1;47(2):228-35 [11933069.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):225-37 [12473464.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Proteins. 2003;53 Suppl 6:430-5 [14579332.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Virol. 1992 Aug;66(8):4874-83 [1629958.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Electrophoresis. 1997 Dec;18(15):2714-23 [9504803.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • (PMID = 18401344.001).
  • [ISSN] 1460-2075
  • [Journal-full-title] The EMBO journal
  • [ISO-abbreviation] EMBO J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, gag
  • [Other-IDs] NLM/ PMC2374847
  •  go-up   go-down


32. Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, Zhang L, Huang Y: Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg; 2009 Oct;36(4):644-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seven days following surgery, 5.0 x 10(9)pfu Ad-SDF-1alpha (adenoviral vector containing human SDF-1alpha gene under the control of the rous sarcoma virus (RSV) promoter), 5.0 x 10(6) Ad-LacZ-MSC or 5.0 x 10(6) Ad-SDF-MSC suspension in a 0.2-ml serum-free medium was injected into four sites in infarcted areas (0.05 ml per site).

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19524448.001).
  • [ISSN] 1873-734X
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chemokine CXCL12; 0 / Vascular Endothelial Growth Factor A; 0 / vascular endothelial growth factor A, rat; EC 1.14.13.39 / Nitric Oxide Synthase Type III; EC 1.14.13.39 / Nos3 protein, rat
  •  go-up   go-down


33. Karagiannidis AI, Bader AG, Hartl M, Bister K: TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif. Virology; 2008 Sep 01;378(2):371-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The TOJ3 gene was originally identified on the basis of its specific activation in avian fibroblasts transformed by the v-jun oncogene of avian sarcoma virus 17 (ASV17).
  • Overexpression of TOJ3 induces cellular transformation of embryonic avian fibroblasts, revealing an intrinsic oncogenic potential.
  • Transforming activity has also been demonstrated for MSP58, the human homolog of TOJ3, and oncogenic cell transformation by MSP58 is specifically inhibited by the tumor suppressor PTEN.
  • [MeSH-major] Avian Proteins / biosynthesis. Nuclear Proteins / biosynthesis. Oncogene Protein p65(gag-jun) / metabolism. Viral Proteins / metabolism
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / physiology. Base Sequence. Binding Sites. Chromatin Immunoprecipitation. Consensus Sequence. Electrophoretic Mobility Shift Assay. Molecular Sequence Data. Promoter Regions, Genetic. Protein Binding. Protein Structure, Tertiary. Transcription Factor AP-1 / metabolism. Transcription, Genetic

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18603277.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Grant] Austria / Austrian Science Fund FWF / / P 17041; Austria / Austrian Science Fund FWF / / P 18148
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Nuclear Proteins; 0 / Oncogene Protein p65(gag-jun); 0 / TOJ3 protein, Coturnix coturnix; 0 / Transcription Factor AP-1; 0 / Viral Proteins
  •  go-up   go-down


34. Kieback DG: Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1. In Vivo; 2009 Jan-Feb;23(1):77-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenoviral (ADV) gene therapy with the thymidine kinase gene (TK) under control of the Rous sarcoma virus (RSV) promotor followed by the administration of acyclovir leads to replication errors in transcription and to cell death.
  • [MeSH-minor] Acyclovir / pharmacology. Adenoviridae / genetics. Antiviral Agents / pharmacology. Cell Line, Tumor. Combined Modality Therapy. Drug Synergism. Female. Genetic Vectors. Humans. Rous sarcoma virus / genetics


35. Busschots K, Vercammen J, Emiliani S, Benarous R, Engelborghs Y, Christ F, Debyser Z: The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J Biol Chem; 2005 May 6;280(18):17841-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have previously shown that the p75 isoform of the transcriptional co-activator lens epithelium-derived growth factor (LEDGF) interacts tightly with human immunodeficiency virus (HIV)-1 integrase (IN) and is essential for nuclear targeting of this protein in human cells (Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z. (2003) J. Biol. Chem.
  • 278, 372-381; Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y. (2003) J. Biol. Chem.
  • In the pull-down assay LEDGF/p75 interacted with HIV-1, HIV-2, and feline immunodeficiency virus IN, but not with the IN of human T-cell lymphotropic virus type 2, Moloney murine leukemia virus, or Rous sarcoma virus.
  • LEDGF/p75 stimulated the binding of HIV-1 and HIV-2 IN, but not Moloney murine leukemia virus or Rous sarcoma virus IN, to an aspecific DNA.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15749713.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Intercellular Signaling Peptides and Proteins; 0 / Protein Isoforms; 0 / lens epithelium-derived growth factor; EC 2.7.7.- / Integrases
  •  go-up   go-down


36. Uckun FM, Erbeck D, Qazi S, Venkatachalam T, Tibbles HE, Vassilev A: Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis. Arzneimittelforschung; 2007;57(6):320-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Familial adenomatous polyposis (FAP) is associated with germ-line mutations in the tumor suppressor gene, adenomatous polyposis coli (APC) located on chromosome 5q21.
  • In contrast, Compound DDE24, a synthetically activated genistein, an inhibitor of Epidermal Growth Factor receptor (EGF-R), cellular homologue of oncogene product from Raus Avian sarcoma virus (SRC) and Syk tyrosine kinases, which Thus, selective targeting of JAK3 was highly effective in preventing development of intestinal tumors in Min mice resulting in markedly improved survival outcomes.

  • COS Scholar Universe. author profiles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17688077.001).
  • [ISSN] 0004-4172
  • [Journal-full-title] Arzneimittel-Forschung
  • [ISO-abbreviation] Arzneimittelforschung
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 0 / Quinazolines; 0 / WHI P131; 0 / beta Catenin; EC 2.7.10.2 / Janus Kinase 3
  •  go-up   go-down


37. Keller PW, Johnson MC, Vogt VM: Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding. J Virol; 2008 Jul;82(14):6788-97
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
  • The Gag proteins of Rous sarcoma virus (RSV) and human immunodeficiency virus type 1 (HIV-1) contain a short spacer peptide (SP or SP1, respectively) separating the capsid (CA) and nucleocapsid (NC) domains.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2005 Dec 23;280(51):42149-55 [16251182.001]
  • [Cites] J Virol. 2006 Jun;80(12):5716-22 [16731910.001]
  • [Cites] J Virol. 2006 Nov;80(22):10957-71 [16956950.001]
  • [Cites] Virology. 2006 Dec 5-20;356(1-2):217-24 [16930665.001]
  • [Cites] PLoS Biol. 2006 Dec;4(12):e435 [17147474.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] Virology. 2007 Apr 10;360(2):388-97 [17156810.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] EMBO J. 2008 May 7;27(9):1411-20 [18401344.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Virol. 1994 Dec;68(12):8017-27 [7966591.001]
  • [Cites] J Virol. 1995 Jun;69(6):3407-19 [7745687.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] J Virol. 1998 Mar;72(3):1782-9 [9499028.001]
  • [Cites] J Virol. 1998 Mar;72(3):2072-8 [9499062.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Virol. 1998 Apr;72(4):2846-54 [9525604.001]
  • [Cites] J Virol. 1998 Jul;72(7):5877-85 [9621049.001]
  • [Cites] Virology. 1998 Aug 1;247(2):160-9 [9705909.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Cell Biol. 1963 Apr;17:208-12 [13986422.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] J Virol. 2000 Jan;74(1):16-23 [10590086.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] J Virol. 2000 Jun;74(12):5395-402 [10823843.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Antimicrob Agents Chemother. 2001 Apr;45(4):1225-30 [11257038.001]
  • [Cites] J Virol. 2001 May;75(9):4407-12 [11287591.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] Biophys J. 2001 Jul;81(1):586-94 [11423440.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Virology. 2002 Jun 20;298(1):30-8 [12093170.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2002 Nov;76(22):11729-37 [12388733.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] J Virol. 2003 Feb;77(3):1772-83 [12525611.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Virol. 2003 Apr;77(8):4794-804 [12663786.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] J Virol. 2003 Jun;77(12):7058-66 [12768025.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60 [14573704.001]
  • [Cites] J Virol. 2003 Dec;77(24):12986-95 [14645555.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] J Virol. 2004 Jan;78(2):551-60 [14694086.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Virol. 2004 Jan;78(2):922-9 [14694123.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] Protein Sci. 2004 Aug;13(8):2101-7 [15238640.001]
  • [Cites] J Virol. 2004 Sep;78(18):9675-88 [15331700.001]
  • [Cites] J Biol Chem. 2004 Sep 17;279(38):39886-94 [15247214.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Ultrastruct Res. 1969 Jan;26(1):31-43 [4887011.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] J Virol. 2005 Feb;79(3):1803-12 [15650204.001]
  • [Cites] Protein Sci. 2005 Feb;14(2):375-86 [15659370.001]
  • [Cites] J Virol. 2005 Apr;79(7):4159-69 [15767417.001]
  • [Cites] Virology. 2005 May 10;335(2):232-41 [15840522.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Virology. 2005 Dec 20;343(2):190-200 [16183096.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • (PMID = 18448521.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI073098-02; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI73098; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / gag protein p19, Rous sarcoma virus
  • [Other-IDs] NLM/ PMC2446955
  •  go-up   go-down


38. Fisher S: Not beyond reasonable doubt: Howard Temin's provirus hypothesis revisited. J Hist Biol; 2010;43(4):661-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Temin's provirus hypothesis offered a simple explanation of both virus replication and viral-induced cancer and stated that Rous sarcoma virus, an RNA virus, is replicated via a DNA intermediate.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1970 Jun 27;226(5252):1211-3 [4316301.001]
  • [Cites] J Hist Biol. 1993 Spring;26(1):89-107 [11612941.001]
  • [Cites] Nature. 1970 Jun 27;226(5252):1209-11 [4316300.001]
  • [Cites] Proc Natl Acad Sci U S A. 1964 Aug;52:323-9 [14206598.001]
  • [Cites] Virology. 1963 Aug;20:577-82 [14059825.001]
  • [Cites] J Gen Physiol. 1966 Jul 1;49(6):263-304 [19873571.001]
  • [Cites] Biogr Mem Fellows R Soc. 1995;41:471-80 [11615362.001]
  • [Cites] Osiris. 1993;8:3-15 [11639582.001]
  • [Cites] Genetics. 1996 Sep;144(1):1-6 [8878668.001]
  • [Cites] Bacteriol Rev. 1971 Sep;35(3):235-41 [4329869.001]
  • [Cites] Hist Philos Life Sci. 2002;24(2):165-92 [12961764.001]
  • [Cites] J Hist Biol. 1994 Spring;27(1):91-139 [11639260.001]
  • [Cites] Nature. 1970 Jun 27;226(5252):1198-9 [5422595.001]
  • [Cites] Symp Soc Exp Biol. 1958;12:138-63 [13580867.001]
  • [Cites] Virology. 1959 Jan;7(1):75-91 [13636057.001]
  • [Cites] Virology. 1960 Feb;10:182-97 [13837371.001]
  • [Cites] J Hist Biol. 2010 Spring;43(1):111-57 [20503720.001]
  • [Cites] J Hist Biol. 1997 Spring;30(1):1-29 [11618978.001]
  • [Cites] Trends Biochem Sci. 1998 Aug;23(8):312-6 [9757833.001]
  • [Cites] Intervirology. 1980;13(5):257-70 [6997231.001]
  • [Cites] Virology. 1961 Feb;13:158-63 [13775833.001]
  • [Cites] Cancer Res. 1964 Aug;24:1085-98 [14209402.001]
  • [Cites] Cancer Res. 1966 Feb;26(2):212-6 [4285551.001]
  • [Cites] Virology. 1958 Dec;6(3):669-88 [13616179.001]
  • [Cites] Proc Natl Acad Sci U S A. 1972 Apr;69(4):1016-20 [4337233.001]
  • [Cites] Virology. 1959 Jun;8(2):209-22 [13669338.001]
  • [Cites] Hist Philos Life Sci. 1999;21(3):293-330 [11197187.001]
  • [Cites] Nature. 1970 Aug 8;227(5258):561-3 [4913914.001]
  • [Cites] Sci Am. 1964 Jun;210:46-52 [14183747.001]
  • [Cites] Science. 1962 Dec 14;138(3546):1270-2 [14028398.001]
  • [Cites] Biogr Mem Natl Acad Sci. 2001;79:336-74 [11762398.001]
  • [Cites] Int J Epidemiol. 2007 Feb;36(1):246-7 [17169945.001]
  • [Cites] Proc Natl Acad Sci U S A. 1966 Jun;55(6):1539-54 [5227673.001]
  • [Cites] Nature. 1967 Sep 2;215(5105):1043-4 [4964084.001]
  • (PMID = 20665081.001).
  • [ISSN] 0022-5010
  • [Journal-full-title] Journal of the history of biology
  • [ISO-abbreviation] J Hist Biol
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article
  • [Publication-country] Germany
  • [Personal-name-as-subject] Temin H
  •  go-up   go-down


39. Zheng C, Baum BJ: Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands. Mol Ther; 2005 Sep;12(3):528-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To optimize vectors for salivary gland gene transfer, we screened viral [cytomegalovirus (CMV; human immediate early), Rous sarcoma virus (RSV), simian virus 40, and Moloney murine leukemia virus long terminal repeat] and mammalian [elongation factor 1alpha (EF1alpha), cytokeratin 18 (K18), cytokeratin 19 (K19), kallikrein (Kall), and amylase (AMY), all human, and rat aquaporin-5 (rAQP5), and derivative elements] promoters driving luciferase activity in vitro and in vivo.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16099414.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Complementary; 147336-22-9 / Green Fluorescent Proteins; EC 1.13.12.- / Luciferases
  •  go-up   go-down


40. Becsei-Kilborn E: Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus. J Hist Biol; 2010;43(1):111-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus.
  • This article concerns itself with the reception of Rous' 1911 discovery of what later came to be known as the Rous Sarcoma Virus (RSV).
  • Rous made his discovery at the Rockefeller Institute for Medical Research which had been primarily established to conduct research into infectious diseases.
  • Rous' chance discovery of a chicken tumor led him to a series of conjectures about cancer causation and about whether cancer could have an extrinsic cause.
  • Rous' finding was received with some scepticism by the scientific community that held that cancer was not infectious and favored explanations which located the origins of cancer in the inner mechanism of the cell.
  • After 4 years of unsuccessful effort to isolate and further determine the virus Rous felt compelled to discontinue his work on cancer viruses.
  • When 55 years later, the significance of Rous's discovery was attested by the award of the Nobel Prize, it opened up debates about the issues of delayed recognition and scientific reputation.
  • This article also considers why Rous' hypothesis of a viral origin of cancer could not be incorporated into the existing body of knowledge about cancer before the 1950s.
  • [MeSH-major] Infection / history. Neoplasms / history. Rous sarcoma virus. Virology / history

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 1910 May 1;12(3):344-66 [19867332.001]
  • [Cites] J Hist Med Allied Sci. 1997 Jan;52(1):7-16 [9071845.001]
  • [Cites] J Exp Med. 1911 Apr 1;13(4):397-411 [19867421.001]
  • [Cites] Nature. 1986 Dec 18-31;324(6098):629-31 [3540684.001]
  • [Cites] Science. 1916 Mar 3;43(1105):293-303 [17782272.001]
  • [Cites] Cancer Res. 1965 Feb;25:75-106 [14264062.001]
  • [Cites] J Exp Med. 1910 Sep 1;12(5):696-705 [19867354.001]
  • [Cites] Perspect Biol Med. 2004 Summer;47(3):357-71 [15247502.001]
  • [Cites] Minerva. 1987 Spring-Summer;25(1-2):171-200 [11621196.001]
  • [Cites] Med Hist. 2001 Jan;45(1):33-60 [11235051.001]
  • [Cites] J Hist Med Allied Sci. 1997 Jan;52(1):17-50 [9071846.001]
  • [Cites] Sci Am. 1972 Dec;227(6):84-93 [4564019.001]
  • [Cites] J Hist Biol. 1999 Spring;32(1):133-62 [11623812.001]
  • [Cites] J Hist Biol. 1994 Spring;27(1):91-139 [11639260.001]
  • [Cites] FASEB J. 1996 Nov;10(13):1559-62 [8940303.001]
  • [Cites] Biosci Rep. 1990 Oct;10(5):413-30 [1704261.001]
  • [Cites] Trends Biochem Sci. 2001 Jul;26(7):454-7 [11440859.001]
  • [Cites] J Exp Med. 1913 Oct 1;18(4):416-27 [19867717.001]
  • [Cites] Cancer Res. 1964 Jan;24:4-27 [14106160.001]
  • [Cites] Hist Sci. 1994 Jun;32(2):185-235 [11639267.001]
  • [Cites] Nature. 1999 Aug 5;400(6744):515 [10448850.001]
  • [Cites] J Exp Med. 1914 Nov 1;20(5):433-51 [19867833.001]
  • [Cites] Biogr Mem Fellows R Soc. 1971;17:643-62 [11615431.001]
  • [Cites] Cancer Res. 1976 Mar;36(3):871-80 [766962.001]
  • [Cites] Virology. 1958 Dec;6(3):669-88 [13616179.001]
  • [Cites] J Exp Med. 1944 Aug 1;80(2):101-26 [19871401.001]
  • [Cites] Hist Philos Life Sci. 1999;21(3):293-330 [11197187.001]
  • [Cites] Cancer Res. 1967 Nov;27(11):1919-24 [6073492.001]
  • [Cites] Rev Am Hist. 1999 Jun;27(2):259-66 [11623768.001]
  • [Cites] Cancer Cells. 1990 Aug-Sep;2(8-9):228-57 [2095763.001]
  • [Cites] J Exp Med. 1914 Oct 1;20(4):419-32 [19867832.001]
  • [Cites] J Natl Cancer Inst. 1985 Feb;74(2):391-403 [3883036.001]
  • [Cites] Nature. 1965 Jul 31;207(996):457-63 [5328672.001]
  • [Cites] JAMA. 1983 Sep 16;250(11):1445-9 [6310170.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 1999 Mar 29;354(1383):675-85 [10212948.001]
  • [Cites] J Lab Clin Med. 2005 Dec;146(6):312-6 [16310512.001]
  • [Cites] J Exp Med. 1914 Jan 1;19(1):52-68 [19867749.001]
  • [Cites] J Hist Biol. 1995 Spring;28(1):49-89 [11639575.001]
  • [Cites] Hist Stud Phys Biol Sci. 1990;21(1):87-98 [11622449.001]
  • (PMID = 20503720.001).
  • [ISSN] 0022-5010
  • [Journal-full-title] Journal of the history of biology
  • [ISO-abbreviation] J Hist Biol
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Personal-name-as-subject] Rous FP
  •  go-up   go-down


41. Moreau K, Charmetant J, Gallay K, Faure C, Verdier G, Ronfort C: Avian sarcoma and leukemia virus (ASLV) integration in vitro: mutation or deletion of integrase (IN) recognition sequences does not prevent but only reduces the efficiency and accuracy of DNA integration. Virology; 2009 Sep 15;392(1):94-102
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Avian sarcoma and leukemia virus (ASLV) integration in vitro: mutation or deletion of integrase (IN) recognition sequences does not prevent but only reduces the efficiency and accuracy of DNA integration.
  • We used an Avian Sarcoma and Leukemia Viruses (ASLV) integration assay to investigate the way in which IN integrates substrates mutated or devoid of one or both IN recognition sequences.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19638332.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral; EC 2.7.7.- / Integrases
  •  go-up   go-down


42. Hyun JK, Radjainia M, Kingston RL, Mitra AK: Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles. J Biol Chem; 2010 May 14;285(20):15056-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles.
  • We have developed an efficient in vitro protocol for studying the assembly of Rous sarcoma virus (RSV) CA that involves mild acidification and produces structures modeling the authentic viral capsid.
  • [MeSH-major] Capsid / chemistry. Protons. Rous sarcoma virus / chemistry

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2006 Apr;80(8):3712-20 [16571788.001]
  • [Cites] FEBS J. 2009 Nov;276(21):6098-109 [19825044.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Biochem Biophys Methods. 2003 Jun 30;56(1-3):15-52 [12834967.001]
  • [Cites] J Virol. 2004 Mar;78(5):2606-8 [14963166.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] Biochim Biophys Acta. 1966 Feb 7;112(2):346-62 [5329026.001]
  • [Cites] Nature. 1970 May 2;226(5244):421-5 [4314822.001]
  • [Cites] Adv Protein Chem. 1970;24:343-446 [4916268.001]
  • [Cites] Biochemistry. 1974 Jan 15;13(2):384-9 [4810059.001]
  • [Cites] Biochemistry. 1974 Apr 23;13(9):1868-74 [4840831.001]
  • [Cites] J Mol Biol. 1974 Sep 15;88(2):327-41 [4452998.001]
  • [Cites] Biophys J. 1989 Jun;55(6):1155-67 [2765653.001]
  • [Cites] Biophys J. 1989 Nov;56(5):887-900 [2557933.001]
  • [Cites] J Virol. 1992 Aug;66(8):4874-83 [1629958.001]
  • [Cites] J Mol Biol. 1994 Aug 5;241(1):59-67 [8051707.001]
  • [Cites] Protein Sci. 1995 Nov;4(11):2411-23 [8563639.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):48-55 [8742722.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):120-30 [8742733.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Struct Biol. 1999 Apr-May;125(2-3):185-95 [10222274.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] Methods Mol Biol. 2005;299:153-74 [15980600.001]
  • [Cites] Retrovirology. 2004;1:9 [15169567.001]
  • [Cites] J Virol. 2005 Nov;79(22):14271-81 [16254362.001]
  • [Cites] Langmuir. 2005 Dec 20;21(26):12085-9 [16342976.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] Biophys J. 2006 Sep 1;91(5):1591-603 [16714342.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] Retrovirology. 2007;4:40 [17565686.001]
  • [Cites] AIDS Rev. 2007 Apr-Jun;9(2):114-25 [17694678.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Virol. 2007 Nov;81(22):12337-47 [17855544.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] Curr Opin Struct Biol. 2008 Apr;18(2):203-17 [18406133.001]
  • [Cites] J Virol. 2008 Jun;82(12):5951-61 [18400856.001]
  • [Cites] Nat Rev Immunol. 2008 Nov;8(11):849-60 [18836477.001]
  • [Cites] Trends Microbiol. 2008 Dec;16(12):612-9 [18976920.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Dec;63(4):862-922, table of contents [10585969.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1498-507 [11285214.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Struct Biol. 2001 Feb-Mar;133(2-3):156-69 [11472087.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] J Virol. 2002 Jul;76(14):6900-8 [12072491.001]
  • [Cites] Biochemistry. 2002 Oct 1;41(39):11525-31 [12269796.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] J Mol Biol. 2009 Mar 27;387(2):376-89 [19356593.001]
  • [Cites] Structure. 2009 May 13;17(5):737-48 [19446529.001]
  • [Cites] J Mol Biol. 2009 Jun 5;389(2):438-51 [19361521.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1820-5 [12351826.001]
  • (PMID = 20228062.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  • [Other-IDs] NLM/ PMC2865289
  •  go-up   go-down


43. Scheifele LZ, Ryan EP, Parent LJ: Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein. J Virol; 2005 Jul;79(14):8732-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein.
  • The Rous sarcoma virus (RSV) Gag polyprotein undergoes transient nuclear trafficking as an intrinsic part of the virus assembly pathway.
  • Consistent with a role for the NES sequence in viral replication, this cluster of hydrophobic residues in p10 is conserved across a wide range of avian retroviruses.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2003 Jun 2;22(11):2841-51 [12773398.001]
  • [Cites] EMBO J. 1997 Aug 1;16(15):4531-9 [9303297.001]
  • [Cites] Virus Res. 2003 Sep;95(1-2):3-12 [12921991.001]
  • [Cites] Trends Biochem Sci. 2003 Aug;28(8):419-24 [12932730.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1041-50 [9323132.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] J Cell Biochem. 1998 Aug 1;70(2):231-9 [9671229.001]
  • [Cites] J Virol. 1998 Sep;72(9):7593-7 [9696859.001]
  • [Cites] J Virol. 1999 Jan;73(1):120-7 [9847314.001]
  • [Cites] J Virol. 1999 Apr;73(4):2667-74 [10074112.001]
  • [Cites] J Virol. 1999 Aug;73(8):6282-92 [10400719.001]
  • [Cites] Mol Cell Biol. 1999 Sep;19(9):6276-85 [10454574.001]
  • [Cites] Genes Dev. 1999 Aug 15;13(16):2118-33 [10465789.001]
  • [Cites] J Biol Chem. 2004 Nov 12;279(46):47473-9 [15364930.001]
  • [Cites] Trends Cell Biol. 2005 Mar;15(3):121-4 [15752974.001]
  • [Cites] J Cell Sci. 2003 Jun 15;116(Pt 12):2409-19 [12724356.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] Annu Rev Cell Dev Biol. 1999;15:607-60 [10611974.001]
  • [Cites] J Virol. 2000 Mar;74(6):2814-25 [10684298.001]
  • [Cites] Cell Struct Funct. 1999 Dec;24(6):425-33 [10698256.001]
  • [Cites] J Virol. 2000 May;74(9):3984-95 [10756010.001]
  • [Cites] Cell. 2000 Apr 14;101(2):187-98 [10786834.001]
  • [Cites] J Virol. 2000 Jul;74(13):5845-55 [10846064.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):359-68 [10860744.001]
  • [Cites] J Cell Biol. 2000 Aug 7;150(3):433-46 [10931858.001]
  • [Cites] Mol Cell Biol. 2000 Oct;20(20):7798-812 [11003674.001]
  • [Cites] J Cell Biol. 2000 Oct 2;151(1):1-14 [11018049.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Cell Biol. 2003 Jul 21;162(2):173-83 [12860972.001]
  • [Cites] Virology. 2003 Sep 30;314(2):591-600 [14554087.001]
  • [Cites] J Biol Chem. 2004 Apr 9;279(15):15356-67 [14729678.001]
  • [Cites] Mol Cell. 2004 Jun 4;14(5):599-610 [15175155.001]
  • [Cites] Microbes Infect. 2004 Jul;6(8):715-24 [15207818.001]
  • [Cites] EMBO J. 2004 Sep 15;23(18):3643-52 [15329671.001]
  • [Cites] Protein Eng Des Sel. 2004 Jun;17(6):527-36 [15314210.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1988 Nov 25;16(22):10881-90 [2849754.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5246-51 [11320254.001]
  • [Cites] Traffic. 2001 Aug;2(8):544-55 [11489212.001]
  • [Cites] Mol Cell. 2001 Aug;8(2):397-406 [11545741.001]
  • [Cites] Microbiol Mol Biol Rev. 2001 Dec;65(4):570-94, table of contents [11729264.001]
  • [Cites] Mol Cell. 2000 Nov;6(5):1243-52 [11106761.001]
  • [Cites] Nat Cell Biol. 2001 Dec;3(12):1092-100 [11781571.001]
  • [Cites] Mol Cell Biol. 2002 Apr;22(7):2057-67 [11884594.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jul;76(14):7220-7 [12072521.001]
  • [Cites] J Virol. 2003 Jun;77(11):6376-84 [12743295.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Jul;67(7):3826-34 [7685400.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9 [7687060.001]
  • [Cites] J Virol. 1995 Jun;69(6):3949-54 [7745752.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Feb;70(2):1016-26 [8551559.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • [Cites] J Virol. 1996 Sep;70(9):6442-5 [8709278.001]
  • [Cites] J Virol. 1996 Dec;70(12):8255-62 [8970944.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Cell Biol. 2000 Oct 30;151(3):653-62 [11062265.001]
  • (PMID = 15994767.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Karyopherins; 0 / Nuclear Localization Signals; 0 / Receptors, Cytoplasmic and Nuclear; 0 / exportin 1 protein
  • [Other-IDs] NLM/ PMC1168749
  •  go-up   go-down


44. Shirodkar MV, Sehgal PB: Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein? Indian J Exp Biol; 2006 Oct;44(10):777-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein?
  • A line of research beginning in the early 1960s with the observation that West Nile virus and, later, several strains of rabies virus could inhibit the development of the Rous sarcoma virus-induced tumor in the wing-web of chicken (a "sarcoma-blockade") eventually culminated in the characterization of a 14-kDa circulating anti-sarcoma and anti-viral activity christened "plasma factor" (PF) which, unlike the interferons, inhibited the replication of diverse RNA-containing viruses, but not of any DNA-containing viruses.
  • [MeSH-major] Avian Proteins / physiology. Cytokines / physiology. DNA-Binding Proteins / physiology. Sarcoma, Avian / physiopathology. Transcription Factors / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131907.001).
  • [ISSN] 0019-5189
  • [Journal-full-title] Indian journal of experimental biology
  • [ISO-abbreviation] Indian J. Exp. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Cytokines; 0 / DNA-Binding Proteins; 0 / Transcription Factors; 0 / YB-2 protein, Gallus gallus
  • [Number-of-references] 39
  •  go-up   go-down


45. Wu X, Qian K, Qin A, Shen H, Wang P, Jin W, Eltahir YM: Recombinant avian leukosis viruses of subgroup J isolated from field infected commercial layer chickens with hemangioma and myeloid leukosis possess an insertion in the E element. Vet Res Commun; 2010 Oct;34(7):619-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recombinant avian leukosis viruses of subgroup J isolated from field infected commercial layer chickens with hemangioma and myeloid leukosis possess an insertion in the E element.
  • BACKGROUND: Five isolates (JS09GY2, JS09GY3, JS09GY4, JS09GY5, and JS09GY6) of avian leukosis virus subgroup J (ALV-J) were isolated from six infected commercial layer flocks displaying both hemangioma and myeloid leukosis (ML), which shared the same parental line, in China in 2009.
  • By full genome sequences analysis, a 19-nucleotide repeat sequence was identified in the primer binding site (PBS)-leader region of isolates JS09GY3 and JS09GY6, located between sites 249 and 250 according to the sequence of reference strain HPRS103, and also present in Rous sarcoma virus strain Schmidt-Ruppin B (RSV-SRB), Rous associated virus type 1 (RAV-1), and Rous associated virus type 2 (RAV-2).
  • [MeSH-major] Avian Leukosis / virology. Avian Leukosis Virus / classification. Avian Leukosis Virus / genetics. Chickens. Hemangioma / veterinary

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1994 Jun 17;269(24):16566-73 [8206973.001]
  • [Cites] Virology. 1986 Sep;153(2):314-7 [3016994.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] Nature. 1996 Nov 21;384(6606):218-9 [8918870.001]
  • [Cites] Vet Pathol. 1997 Mar;34(2):127-37 [9066079.001]
  • [Cites] J Virol. 1997 May;71(5):3458-65 [9094617.001]
  • [Cites] Avian Dis. 1998 Apr-Jun;42(2):375-80 [9645329.001]
  • [Cites] J Gen Virol. 2006 Sep;87(Pt 9):2685-92 [16894209.001]
  • [Cites] Avian Dis. 2006 Sep;50(3):342-7 [17039832.001]
  • [Cites] Arch Virol. 2006 Dec;151(12):2431-46 [16906478.001]
  • [Cites] Avian Dis. 2006 Dec;50(4):572-8 [17274296.001]
  • [Cites] J Biol Chem. 2007 Dec 21;282(51):36837-44 [17928287.001]
  • [Cites] Avian Dis. 2007 Dec;51(4):942-53 [18251406.001]
  • [Cites] Avian Pathol. 2008 Apr;37(2):127-37 [18393089.001]
  • [Cites] Bing Du Xue Bao. 2008 Sep;24(5):369-75 [19035326.001]
  • [Cites] Avian Dis. 2004 Jan-Mar;48(1):61-7 [15077798.001]
  • [Cites] Avian Dis. 2003 Oct-Dec;47(4):1321-30 [14708978.001]
  • [Cites] Avian Pathol. 2004 Feb;33(1):13-7 [14681063.001]
  • [Cites] Cancer Res. 2003 Jul 15;63(14):3855-9 [12873972.001]
  • [Cites] Avian Dis. 2002 Jul-Sep;46(3):745-8 [12243545.001]
  • [Cites] J Gen Virol. 2002 Oct;83(Pt 10):2553-61 [12237439.001]
  • [Cites] Blood. 2002 Feb 15;99(4):1388-97 [11830491.001]
  • [Cites] Avian Dis. 2001 Oct-Dec;45(4):938-45 [11785897.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):27-30 [10592173.001]
  • [Cites] J Gen Virol. 1992 Nov;73 ( Pt 11):2995-7 [1331300.001]
  • [Cites] EMBO J. 1992 Oct;11(10):3747-57 [1327749.001]
  • [Cites] J Gen Virol. 1991 Apr;72 ( Pt 4):801-7 [1849967.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Exp Cell Res. 1996 Feb 1;222(2):370-8 [8598225.001]
  • (PMID = 20676760.001).
  • [ISSN] 1573-7446
  • [Journal-full-title] Veterinary research communications
  • [ISO-abbreviation] Vet. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA Transposable Elements
  • [Other-IDs] NLM/ PMC2931761
  •  go-up   go-down


46. Plachy J, Kotáb J, Divina P, Reinisová M, Senigl F, Hejnar J: Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas. J Virol; 2010 May;84(9):4204-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report here the cloning and characterization of avian sarcoma virus integration sites from chicken tumors.
  • Analysis of integration sites from avian sarcoma virus-induced tumors showed strikingly nonrandom distribution, with proviruses found prevalently within or close to transcription units, particularly in genes broadly expressed in multiple tissues but not in tissue-specifically expressed genes.
  • [MeSH-major] Avian Sarcoma Viruses / physiology. Chromosomes / virology. Proviruses / physiology. Sarcoma, Avian / virology. Virus Integration

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 2002 Sep;32(1):166-74 [12185365.001]
  • [Cites] J Virol. 2007 Jun;81(12):6731-41 [17409138.001]
  • [Cites] EMBO J. 2003 Apr 15;22(8):1868-77 [12682019.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] J Gen Virol. 1981 Nov;57(Pt 1):85-94 [6275023.001]
  • [Cites] Gene. 1991 Oct 15;106(2):165-72 [1657723.001]
  • [Cites] Immunogenetics. 1992;35(5):309-15 [1348493.001]
  • [Cites] Cell Growth Differ. 1994 Mar;5(3):277-85 [8018560.001]
  • [Cites] Virology. 1994 Sep;203(2):211-20 [8053145.001]
  • [Cites] PLoS Comput Biol. 2006 Dec 8;2(12):e166 [17154714.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] J Virol. 2008 Feb;82(3):1360-7 [18032509.001]
  • [Cites] PLoS Pathog. 2008 Mar;4(3):e1000027 [18369476.001]
  • [Cites] Mol Ther. 2008 Sep;16(9):1617-23 [18578011.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):309-21 [18709449.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3132-42 [18688285.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D5-15 [18940862.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D690-7 [19033362.001]
  • [Cites] Genes Dev. 2009 Mar 1;23(5):633-42 [19270161.001]
  • [Cites] Nat Rev Genet. 2009 Jul;10(7):457-66 [19506577.001]
  • [Cites] PLoS Pathog. 2009 Jul;5(7):e1000522 [19609362.001]
  • [Cites] AIDS. 2009 Jul 31;23(12):1461-71 [19550285.001]
  • [Cites] Trends Microbiol. 1999 Nov;7(11):431; author reply 431-2 [10542420.001]
  • [Cites] Curr Opin Genet Dev. 1999 Dec;9(6):657-63 [10607616.001]
  • [Cites] J Virol. 2000 Sep;74(18):8382-9 [10954538.001]
  • [Cites] Adv Genet. 2001;43:33-69 [11037298.001]
  • [Cites] Science. 2001 Feb 16;291(5507):1289-92 [11181992.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):565-9 [11209056.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1726-38 [11285236.001]
  • [Cites] Gene. 2001 Oct 3;276(1-2):39-45 [11591470.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] FEBS Lett. 2002 Apr 24;517(1-3):285-6 [12062454.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Immunogenetics. 1994;40(4):257-65 [8082891.001]
  • [Cites] Hum Gene Ther. 1995 Sep;6(9):1203-13 [8527479.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1436-41 [15659548.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1275-6 [15677323.001]
  • [Cites] J Virol. 2005 Apr;79(8):5211-4 [15795304.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • [Cites] J Virol. 2005 Jun;79(11):6610-9 [15890899.001]
  • [Cites] J Virol. 2005 Sep;79(18):12035-44 [16140779.001]
  • [Cites] Nat Med. 2005 Dec;11(12):1287-9 [16311605.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):78-86 [16397219.001]
  • [Cites] Trends Genet. 2006 Jul;22(7):388-95 [16730094.001]
  • [Cites] Gene. 2002 Oct 30;300(1-2):169-78 [12468098.001]
  • (PMID = 20147411.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2863777
  •  go-up   go-down


47. Andrake MD, Sauter MM, Boland K, Goldstein AD, Hussein M, Skalka AM: Nuclear import of Avian Sarcoma Virus integrase is facilitated by host cell factors. Retrovirology; 2008 Aug 07;5:73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nuclear import of Avian Sarcoma Virus integrase is facilitated by host cell factors.
  • In previous reports we identified a sequence (amino acids 201-236) in the linker region between the catalytic core and C-terminal domains of the avian sarcoma virus (ASV) integrase protein that functions as a transferable nuclear localization signal (NLS) in mammalian cells.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Methods Cell Biol. 1991;35:469-82 [1779864.001]
  • [Cites] Cell. 1991 Feb 8;64(3):615-23 [1991323.001]
  • [Cites] J Cell Biol. 1994 May;125(3):547-55 [8175880.001]
  • [Cites] Trends Biochem Sci. 1994 May;19(5):211-6 [7519373.001]
  • [Cites] Cell. 1994 Dec 2;79(5):767-78 [8001116.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1769-73 [7878057.001]
  • [Cites] J Cell Biol. 1995 May;129(4):925-37 [7744965.001]
  • [Cites] J Cell Biol. 1995 Jul;130(2):265-74 [7615630.001]
  • [Cites] EMBO J. 1995 Aug 1;14(15):3617-26 [7641681.001]
  • [Cites] J Biol Chem. 1995 Dec 8;270(49):29299-306 [7493962.001]
  • [Cites] Science. 1996 Mar 15;271(5255):1513-8 [8599106.001]
  • [Cites] J Virol. 1997 Jan;71(1):843-7 [8985428.001]
  • [Cites] Exp Cell Res. 1996 Dec 15;229(2):261-6 [8986607.001]
  • [Cites] EMBO J. 1997 Mar 17;16(6):1153-63 [9135132.001]
  • [Cites] J Cell Biol. 1998 Nov 16;143(4):875-85 [9817747.001]
  • [Cites] J Biol Chem. 1998 Dec 25;273(52):35170-5 [9857054.001]
  • [Cites] Gene. 1998 Nov 26;223(1-2):157-63 [9858717.001]
  • [Cites] Adv Virus Res. 1999;52:275-99 [10384238.001]
  • [Cites] Eur J Cell Biol. 2004 Oct;83(10):511-20 [15679097.001]
  • [Cites] J Cell Biochem. 2005 Apr 1;94(5):880-9 [15669021.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):20883-90 [16704975.001]
  • [Cites] Biochem J. 2006 Sep 15;398(3):475-84 [16716146.001]
  • [Cites] Retrovirology. 2006;3:74 [17067381.001]
  • [Cites] PLoS Biol. 2006 Oct;4(10):e332 [17020411.001]
  • [Cites] Nat Rev Microbiol. 2007 Mar;5(3):187-96 [17304248.001]
  • [Cites] J Biol Chem. 2007 May 4;282(18):13456-67 [17360709.001]
  • [Cites] J Biol Chem. 2007 Sep 21;282(38):27685-92 [17652081.001]
  • [Cites] Science. 2008 Feb 15;319(5865):921-6 [18187620.001]
  • [Cites] J Cell Biol. 2000 Jan 24;148(2):293-303 [10648562.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):535-48 [10669607.001]
  • [Cites] J Biol Chem. 2001 May 18;276(20):16824-32 [11278401.001]
  • [Cites] Genome Biol. 2001;2(6):REVIEWS3008 [11423015.001]
  • [Cites] EMBO Rep. 2001 Aug;2(8):690-6 [11493596.001]
  • [Cites] J Virol. 2001 Oct;75(19):9526-31 [11533215.001]
  • [Cites] EMBO J. 2002 Feb 1;21(3):377-86 [11823430.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] J Virol. 2002 Jun;76(12):6205-12 [12021354.001]
  • [Cites] J Cell Biol. 2002 Jun 10;157(6):963-74 [12058015.001]
  • [Cites] J Biol Chem. 2002 Sep 6;277(36):32480-9 [12080050.001]
  • [Cites] J Cell Biol. 2002 Oct 14;159(1):55-67 [12370244.001]
  • [Cites] Mol Cell. 2002 Dec;10(6):1345-53 [12504010.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] J Virol. 2003 Dec;77(24):13412-7 [14645598.001]
  • [Cites] J Virol. 2004 May;78(9):4902-6 [15078971.001]
  • [Cites] J Immunol Methods. 1982;50(2):193-204 [6806389.001]
  • [Cites] J Cell Biol. 1983 May;96(5):1486-90 [6601661.001]
  • [Cites] Cell. 1984 Jul;37(3):801-13 [6086146.001]
  • [Cites] Cell. 1984 Dec;39(3 Pt 2):499-509 [6096007.001]
  • [Cites] Nature. 1986 Aug 14-20;322(6080):641-4 [3638500.001]
  • [Cites] J Cell Biol. 1987 Feb;104(2):189-200 [3805121.001]
  • [Cites] J Biol Chem. 1987 Jul 15;262(20):9887-94 [3110163.001]
  • [Cites] Exp Cell Res. 1988 Jan;174(1):291-6 [3335228.001]
  • [Cites] Cell. 1988 Mar 11;52(5):641-53 [3345567.001]
  • [Cites] Cell. 1988 Mar 11;52(5):655-64 [3125984.001]
  • [Cites] J Cell Biol. 1990 Sep;111(3):807-16 [2391365.001]
  • [Cites] Science. 1992 Nov 6;258(5084):942-7 [1439805.001]
  • (PMID = 18687138.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA071515; United States / NIAID NIH HHS / AI / F32AI09924; United States / NCI NIH HHS / CA / CA071515; United States / NIAID NIH HHS / AI / AI040385; United States / NIAID NIH HHS / AI / F32 AI009924; United States / NCI NIH HHS / CA / CA006927; United States / NIAID NIH HHS / AI / R01 AI040385; United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Histones; 0 / Nuclear Localization Signals; 0 / Viral Proteins; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2527327
  •  go-up   go-down


48. Navratil AM, Knoll JG, Whitesell JD, Tobet SA, Clay CM: Neuroendocrine plasticity in the anterior pituitary: gonadotropin-releasing hormone-mediated movement in vitro and in vivo. Endocrinology; 2007 Apr;148(4):1736-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In live murine pituitary slices infected with an adenovirus-containing Rous sarcoma virus-green fluorescent protein, selected cells responded to GnRH by altering their cellular movements characterized by both formation and extension of cell processes and, surprisingly, spatial repositioning.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17218416.001).
  • [ISSN] 0013-7227
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 33515-09-2 / Gonadotropin-Releasing Hormone
  •  go-up   go-down


49. Dalton AK, Murray PS, Murray D, Vogt VM: Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol; 2005 May;79(10):6227-38
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.
  • We have used an in vitro flotation assay to directly measure Rous sarcoma virus (RSV) MA-membrane interaction in the absence of host cell factors.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 1996 Apr;70(4):2664-8 [8642704.001]
  • [Cites] Biochemistry. 1996 Apr 2;35(13):3933-43 [8672424.001]
  • [Cites] Biophys J. 1996 Aug;71(2):561-75 [8842196.001]
  • [Cites] J Virol. 1996 Dec;70(12):8540-8 [8970978.001]
  • [Cites] Virology. 1972 Nov;50(2):550-7 [4344196.001]
  • [Cites] J Mol Biol. 1979 Jul 15;131(4):819-37 [229234.001]
  • [Cites] J Biol Chem. 1980 Oct 10;255(19):9044-50 [6251073.001]
  • [Cites] Biochim Biophys Acta. 1982 Jul 28;689(2):393-402 [6288099.001]
  • [Cites] Protein Eng. 1998 Sep;11(9):739-47 [9796821.001]
  • [Cites] Cell. 1998 Dec 11;95(6):847-58 [9865702.001]
  • [Cites] J Virol. 1999 Mar;73(3):1902-8 [9971769.001]
  • [Cites] J Virol. 1999 Apr;73(4):2604-12 [10074105.001]
  • [Cites] J Virol. 1999 May;73(5):4136-44 [10196310.001]
  • [Cites] Biochemistry. 1999 Jun 22;38(25):8056-63 [10387050.001]
  • [Cites] J Virol. 1999 Aug;73(8):7050-5 [10400808.001]
  • [Cites] Biophys J. 1999 Dec;77(6):3176-88 [10585939.001]
  • [Cites] Virology. 2000 Feb 15;267(2):289-98 [10662624.001]
  • [Cites] J Mol Biol. 2000 Feb 25;296(3):887-98 [10677289.001]
  • [Cites] J Virol. 2000 Mar;74(6):2855-66 [10684302.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Jun;74(11):5142-50 [10799589.001]
  • [Cites] J Virol. 1997 May;71(5):3474-83 [9094619.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Sep;71(9):6582-92 [9261380.001]
  • [Cites] Structure. 1997 Aug 15;5(8):985-9 [9309215.001]
  • [Cites] Biophys J. 1997 Oct;73(4):1717-27 [9336168.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Pac Symp Biocomput. 1996;:53-72 [9390223.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2145-59 [9485361.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):161-9 [9514761.001]
  • [Cites] J Virol. 1998 Apr;72(4):2723-32 [9525590.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Mol Biol. 1998 Jun 19;279(4):921-8 [9642071.001]
  • [Cites] Biophys J. 1998 Aug;75(2):769-76 [9675178.001]
  • [Cites] J Virol. 1998 Sep;72(9):7659-63 [9696871.001]
  • [Cites] J Virol. 2003 Apr;77(8):4805-17 [12663787.001]
  • [Cites] Traffic. 2003 Apr;4(4):201-13 [12694559.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5795-800 [12721375.001]
  • [Cites] J Biol Chem. 2003 Jul 25;278(30):27923-9 [12761222.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Proteins. 2003;53 Suppl 6:430-5 [14579332.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] Traffic. 2003 Dec;4(12):902-10 [14617353.001]
  • [Cites] Cell. 2003 Nov 14;115(4):377-88 [14622593.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):517-22 [14699046.001]
  • [Cites] Physiol Rev. 2004 Jul;84(3):699-730 [15269334.001]
  • [Cites] J Virol. 2004 Sep;78(17):9560-3 [15308748.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94 [15465916.001]
  • [Cites] Virology. 1971 Oct;46(1):106-16 [4108030.001]
  • [Cites] Anal Biochem. 1972 Jun;47(2):614-9 [4338619.001]
  • [Cites] J Mol Biol. 2000 May 19;298(5):841-57 [10801353.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):499-520 [10860755.001]
  • [Cites] J Mol Biol. 2000 Jun 30;300(1):103-12 [10864502.001]
  • [Cites] Bioinformatics. 2000 Apr;16(4):404-5 [10869041.001]
  • [Cites] J Mol Biol. 2000 Aug 4;301(1):173-90 [10926500.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Virus Res. 2001 Jul;76(1):103-13 [11376850.001]
  • [Cites] J Mol Biol. 2001 Jun 29;310(1):243-57 [11419950.001]
  • [Cites] J Virol. 2001 Sep;75(17):7913-24 [11483736.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30 [11717449.001]
  • [Cites] J Virol. 2002 Feb;76(4):1876-83 [11799182.001]
  • [Cites] Mol Cell. 2002 Jan;9(1):145-54 [11804593.001]
  • [Cites] Proteins. 2002 May 1;47(2):228-35 [11933069.001]
  • [Cites] J Clin Invest. 2002 Sep;110(5):597-603 [12208858.001]
  • [Cites] Structure. 2002 Dec;10(12):1627-36 [12467570.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] Methods Biochem Anal. 2003;44:427-40 [12647398.001]
  • [Cites] J Virol. 1984 Oct;52(1):145-53 [6090691.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] Proteins. 1991;11(4):281-96 [1758883.001]
  • [Cites] Biochemistry. 1992 Feb 18;31(6):1767-73 [1737030.001]
  • [Cites] Nature. 1992 Mar 5;356(6364):83-5 [1538787.001]
  • [Cites] Proteins. 1992 Apr;13(2):112-9 [1620693.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181-5 [8389472.001]
  • [Cites] J Virol. 1993 Sep;67(9):5550-61 [8394460.001]
  • [Cites] Biochemistry. 1993 Oct 5;32(39):10436-43 [8399188.001]
  • [Cites] J Virol. 1993 Nov;67(11):6387-94 [8411340.001]
  • [Cites] J Virol. 1993 Nov;67(11):6487-98 [8411352.001]
  • [Cites] J Virol. 1994 Apr;68(4):2556-69 [8139035.001]
  • [Cites] J Virol. 1994 May;68(5):3232-42 [8151785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 [8183954.001]
  • [Cites] J Virol. 1994 Aug;68(8):5311-20 [8035531.001]
  • [Cites] J Virol. 1994 Oct;68(10):6644-54 [7521919.001]
  • [Cites] Biochemistry. 1994 Nov 8;33(44):13093-101 [7947714.001]
  • [Cites] J Mol Biol. 1994 Nov 25;244(2):198-223 [7966331.001]
  • [Cites] Virology. 1994 Nov 15;205(1):336-44 [7975229.001]
  • [Cites] Science. 1995 May 26;268(5214):1144-9 [7761829.001]
  • [Cites] Trends Biochem Sci. 1995 Jul;20(7):272-6 [7667880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 [8610175.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • (PMID = 15858007.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI54167
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Liposomes; 0 / MA protein, Rous sarcoma virus; 0 / Phosphoproteins; 0 / Viral Matrix Proteins
  • [Other-IDs] NLM/ PMC1091718
  •  go-up   go-down


50. Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD: Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther; 2007 Feb;15(2):320-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The strongest cassette, MHCK7 (770 bp), directs high-level expression comparable to cytomegalovirus and Rous sarcoma virus promoters in fast and slow skeletal and cardiac muscle, and low expression in the liver, lung, and spleen following systemic rAAV6 delivery in mice.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17235310.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / T32 HD007183; United States / NICHD NIH HHS / HD / 1 U54 HD047175; United States / NIAMS NIH HHS / AR / R01 AR18860; United States / NHLBI NIH HHS / HL / R24 HL64387
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.3.2 / Creatine Kinase; EC 3.6.1.- / Ventricular Myosins
  •  go-up   go-down


51. Bridgeman A, Roshorm Y, Lockett LJ, Xu ZZ, Hopkins R, Shaw J, Both GW, Hanke T: Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine. Vaccine; 2009 Dec 11;28(2):474-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OAdV.HIVA was genetically stable, grew well and expressed high levels of protein from the Rous sarcoma virus promoter.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19853074.001).
  • [ISSN] 1873-2518
  • [Journal-full-title] Vaccine
  • [ISO-abbreviation] Vaccine
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U137884179; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / AIDS Vaccines
  •  go-up   go-down


52. Garbitt-Hirst R, Kenney SP, Parent LJ: Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging. J Virol; 2009 Jul;83(13):6790-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.
  • We discovered that the Rous sarcoma virus (RSV) Gag protein transiently localizes to the nucleus, although the roles of Gag nuclear trafficking in virus replication have not been fully elucidated.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dev Cell. 2003 Jul;5(1):161-74 [12852860.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Virol. 2003 Sep;77(17):9431-8 [12915558.001]
  • [Cites] Traffic. 2005 Sep;6(9):741-55 [16101678.001]
  • [Cites] Retrovirology. 2005;2:68 [16274484.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] Traffic. 2006 Sep;7(9):1177-93 [17004321.001]
  • [Cites] Traffic. 2006 Nov;7(11):1440-50 [16984406.001]
  • [Cites] Traffic. 2007 Apr;8(4):347-58 [17286805.001]
  • [Cites] Virology. 2007 Jul 5;363(2):376-86 [17328934.001]
  • [Cites] Retrovirology. 2007;4:54 [17683545.001]
  • [Cites] J Virol. 2007 Oct;81(20):11226-35 [17686839.001]
  • [Cites] J Virol. 2008 Jan;82(2):683-91 [17977961.001]
  • [Cites] J Virol. 2008 Mar;82(5):2501-14 [18094177.001]
  • [Cites] Traffic. 2008 Sep;9(10):1717-27 [18627573.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] EMBO J. 2004 Jul 7;23(13):2632-40 [15201866.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] Cell. 1999 Dec 23;99(7):677-90 [10619422.001]
  • [Cites] Structure. 2000 Mar 15;8(3):329-38 [10745017.001]
  • [Cites] J Virol. 2000 Oct;74(19):9167-74 [10982363.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] EMBO J. 2000 Dec 15;19(24):6751-8 [11118210.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] J Virol. 2001 Jan;75(1):408-19 [11119609.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2003 Feb;77(3):2010-20 [12525635.001]
  • [Cites] Genes Dev. 2004 Sep 1;18(17):2046-59 [15342487.001]
  • [Cites] Virology. 1978 Jan;84(1):87-98 [74124.001]
  • [Cites] J Cell Biol. 1988 Sep;107(3):841-9 [3417784.001]
  • [Cites] J Biol Chem. 1988 Dec 5;263(34):18545-52 [3192548.001]
  • [Cites] Nature. 1989 Mar 16;338(6212):254-7 [2784194.001]
  • [Cites] Cell. 1989 Jun 30;57(7):1155-65 [2736624.001]
  • [Cites] J Virol. 1990 Feb;64(2):847-55 [2153248.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] Cell. 1991 Feb 8;64(3):615-23 [1991323.001]
  • [Cites] Cell. 1991 Oct 4;67(1):117-30 [1913813.001]
  • [Cites] J Virol. 1992 Aug;66(8):4662-70 [1378506.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 [8108397.001]
  • [Cites] J Virol. 1994 Aug;68(8):4946-54 [8035493.001]
  • [Cites] J Virol. 1994 Dec;68(12):7944-52 [7966585.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] Cell. 1995 Aug 11;82(3):475-83 [7543368.001]
  • [Cites] J Virol. 1995 Sep;69(9):5716-22 [7637017.001]
  • [Cites] J Virol. 1995 Oct;69(10):6445-56 [7666546.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 1996 Aug;70(8):5255-65 [8764035.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] EMBO J. 1997 Jul 16;16(14):4276-84 [9250671.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):767-75 [9368759.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7500-10 [9405378.001]
  • [Cites] EMBO J. 1998 Jan 2;17(1):288-96 [9427762.001]
  • [Cites] Genes Dev. 1998 Mar 15;12(6):868-79 [9512520.001]
  • [Cites] Virology. 1998 Jun 20;246(1):1-23 [9656989.001]
  • [Cites] Mol Cell. 1998 Apr;1(5):649-59 [9660949.001]
  • [Cites] J Virol. 2004 Dec;78(24):13534-42 [15564464.001]
  • [Cites] J Biol Chem. 2009 May 22;284(21):14572-85 [19286658.001]
  • (PMID = 19369339.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nuclear Localization Signals; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2698546
  •  go-up   go-down


53. Bowers WJ, Mastrangelo MA, Howard DF, Southerland HA, Maguire-Zeiss KA, Federoff HJ: Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther; 2006 Mar;13(3):580-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cotransduction with a Rous sarcoma virus promoter-driven beta-galactosidase-neomycin (betageo) fusion flanked by SB terminal repeats (HSVT-betageo) and a second expressing the SB transposase gene under HSV immediate-early 4/5 gene promoter control (HSVsb) resulted in integration and extension of expression duration.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Mol Ther. 2006 Mar;13(3):457-8 [16461007.001]
  • (PMID = 16412694.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Grant] United States / NINDS NIH HHS / NS / R01-NS36420A; United States / NINDS NIH HHS / NS / U54-NS045309
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.7.- / Transposases; EC 2.7.7.- / sleeping beauty transposase, human; EC 3.2.1.23 / beta-Galactosidase
  •  go-up   go-down


54. Weil JE, Hadjithomas M, Beemon KL: Structural characterization of the Rous sarcoma virus RNA stability element. J Virol; 2009 Mar;83(5):2119-29
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Structural characterization of the Rous sarcoma virus RNA stability element.
  • We previously identified the Rous sarcoma virus (RSV) stability element (RSE), an RNA element downstream of the gag natural translation termination codon that prevents degradation of the unspliced viral RNA.
  • The overall secondary structure of the RSE appears to be conserved among 20 different avian retroviruses.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 1999 Nov;10(11):3971-8 [10564284.001]
  • [Cites] Annu Rev Genet. 1999;33:229-60 [10690409.001]
  • [Cites] Cell. 2000 Jun 23;101(7):741-51 [10892745.001]
  • [Cites] Am J Hum Genet. 2000 Aug;67(2):345-56 [10889045.001]
  • [Cites] Gene. 2001 Oct 3;276(1-2):73-81 [11591473.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] EMBO J. 2003 Aug 1;22(15):3960-70 [12881430.001]
  • [Cites] Genome Biol. 2003;5(1):R2 [14709174.001]
  • [Cites] J Virol. 2004 May;78(10):5139-46 [15113896.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 11;101(19):7287-92 [15123812.001]
  • [Cites] Nat Genet. 2004 Oct;36(10):1073-8 [15448691.001]
  • [Cites] J Biol Chem. 1981 Jun 25;256(12):6430-4 [6165717.001]
  • [Cites] J Gen Virol. 1983 Oct;64 (Pt 10):2191-202 [6311951.001]
  • [Cites] J Virol. 1986 Nov;60(2):450-9 [2430109.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] Mol Cell Biol. 1991 May;11(5):2760-8 [1850103.001]
  • [Cites] Mol Cell Biol. 1993 Jun;13(6):3340-9 [8497255.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1986-96 [8114730.001]
  • [Cites] Methods Mol Biol. 1994;25:307-18 [8004173.001]
  • [Cites] EMBO J. 1997 Jul 1;16(13):4107-16 [9233819.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Nature. 2004 Nov 4;432(7013):112-8 [15525991.001]
  • [Cites] Genome Biol. 2005;6(1):R6 [15642098.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):477-92 [15670598.001]
  • [Cites] J Am Chem Soc. 2005 Nov 16;127(45):15714-5 [16277508.001]
  • [Cites] RNA. 2006 Jan;12(1):102-10 [16301601.001]
  • [Cites] Nucleic Acids Res. 2005;33(22):7138-50 [16391004.001]
  • [Cites] Nat Struct Mol Biol. 2006 May;13(5):462-4 [16622410.001]
  • [Cites] RNA. 2006 Jul;12(7):1304-14 [16682565.001]
  • [Cites] J Am Chem Soc. 2007 Apr 11;129(14):4144-5 [17367143.001]
  • [Cites] Nat Protoc. 2006;1(3):1610-6 [17406453.001]
  • [Cites] FEBS Lett. 2007 Jun 19;581(15):2845-53 [17531985.001]
  • [Cites] Cell. 2008 Jan 11;132(1):9-14 [18191211.001]
  • [Cites] Mol Cell. 2008 Jan 18;29(1):134-40 [18206975.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e92 [18447580.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e96 [18447581.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e111 [18447585.001]
  • [Cites] RNA. 2008 Jul;14(7):1255-63 [18515544.001]
  • (PMID = 19091866.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NIGMS NIH HHS / GM / 5T32 GM007231-33; United States / NCI NIH HHS / CA / R01 CA48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2643715
  •  go-up   go-down


55. Butan C, Lokhandwala PM, Purdy JG, Cardone G, Craven RC, Steven AC: Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study. J Virol; 2010 Jul;84(13):6377-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.
  • Gag is then processed proteolytically, releasing the capsid protein (CA) to assemble de novo inside maturing virions.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Biol. 2009 Jun 5;389(2):438-51 [19361521.001]
  • [Cites] Structure. 2009 May 13;17(5):737-48 [19446529.001]
  • [Cites] J Struct Biol. 2005 Oct;152(1):36-51 [16182563.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Mol Biol. 2001 Mar 2;306(4):783-97 [11243788.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Struct Biol. 2001 Sep;135(3):239-50 [11722164.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1996 Jun;70(6):3440-8 [8648676.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] Virology. 1996 Aug 15;222(2):339-51 [8806518.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7 [17146053.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] J Gen Virol. 1997 Mar;78 ( Pt 3):637-40 [9049415.001]
  • [Cites] EMBO J. 1999 Mar 1;18(5):1124-36 [10064580.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] J Struct Biol. 2005 Aug;151(2):117-29 [15964766.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] J Virol. 2008 Jun;82(12):5951-61 [18400856.001]
  • [Cites] Virology. 2008 Jun 20;376(1):191-8 [18433823.001]
  • [Cites] Microbiol Immunol. 2008 May;52(5):287-95 [18557900.001]
  • [Cites] Cell Host Microbe. 2008 Dec 11;4(6):592-9 [19064259.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • (PMID = 20427531.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / CA100322; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins
  • [Other-IDs] NLM/ PMC2903260
  •  go-up   go-down


56. Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams PD, Skalka AM, Katz RA: Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol; 2008 Mar;82(5):2313-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously isolated HeLa cell populations that harbored silent avian sarcoma virus-based green fluorescent protein (GFP) vectors that could be reactivated by treatment with HDAC inhibitors.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Methods. 2006 Sep;3(9):677-81 [16929311.001]
  • [Cites] Genome Biol. 2007;8(11):228 [18036274.001]
  • [Cites] Nat Rev Genet. 2007 Jan;8(1):35-46 [17173056.001]
  • [Cites] Nat Biotechnol. 2007 Jan;25(1):84-90 [17211407.001]
  • [Cites] Mol Cell. 2007 Jan 12;25(1):1-14 [17218267.001]
  • [Cites] Mol Cell. 2007 Jan 12;25(1):15-30 [17218268.001]
  • [Cites] Nat Rev Microbiol. 2007 Feb;5(2):95-106 [17224919.001]
  • [Cites] Mol Cell Biol. 2007 Feb;27(3):949-62 [17101789.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):377-82 [10618426.001]
  • [Cites] J Virol. 2000 Aug;74(15):6790-9 [10888618.001]
  • [Cites] Cytogenet Cell Genet. 2000;90(3-4):279-84 [11124534.001]
  • [Cites] Gene. 2000 Dec 30;261(1):181-8 [11164049.001]
  • [Cites] Nature. 2001 Aug 2;412(6846):561-5 [11484059.001]
  • [Cites] EMBO J. 2002 Mar 1;21(5):1112-20 [11867539.001]
  • [Cites] Curr Biol. 2002 Apr 2;12(7):594-8 [11937030.001]
  • [Cites] Mol Cell Biol. 2002 May;22(9):2965-73 [11940654.001]
  • [Cites] J Virol. 2002 May;76(10):5034-42 [11967319.001]
  • [Cites] J Biol Chem. 2002 May 3;277(18):15859-64 [11850427.001]
  • [Cites] J Virol. 2002 Jun;76(11):5769-83 [11992005.001]
  • [Cites] J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30 [12140263.001]
  • [Cites] J Hematother Stem Cell Res. 2002 Jun;11(3):449-56 [12183830.001]
  • [Cites] Nat Genet. 2003 Mar;33 Suppl:245-54 [12610534.001]
  • [Cites] Biochem J. 2003 Mar 15;370(Pt 3):737-49 [12429021.001]
  • [Cites] Mol Cell. 2003 Dec;12(6):1537-49 [14690606.001]
  • [Cites] AIDS. 2004 May 21;18(8):1101-8 [15166525.001]
  • [Cites] Mol Ther. 2004 Jul;10(1):27-36 [15233939.001]
  • [Cites] Nat Cell Biol. 2004 Aug;6(8):784-91 [15247924.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Hum Gene Ther. 2005 Nov;16(11):1241-6 [16259557.001]
  • [Cites] Gene. 2005 Dec 19;363:15-23 [16289629.001]
  • [Cites] EMBO J. 2006 Jan 11;25(1):139-49 [16319923.001]
  • [Cites] Nat Methods. 2006 Mar;3(3):199-204 [16489337.001]
  • [Cites] Trends Microbiol. 2006 Mar;14(3):132-40 [16458005.001]
  • [Cites] J Virol. 2006 Apr;80(8):3863-71 [16571803.001]
  • [Cites] J Gen Virol. 2006 May;87(Pt 5):1113-21 [16603511.001]
  • [Cites] Nat Cell Biol. 2006 Apr;8(4):407-15 [16531993.001]
  • [Cites] J Virol. 2006 Jun;80(12):6188-91 [16731959.001]
  • [Cites] Trends Genet. 1997 Aug;13(8):335-40 [9260521.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):549-61 [15546615.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17234-9 [15572445.001]
  • [Cites] Bull Mem Acad R Med Belg. 2004;159(Pt 2):176-89 [15615091.001]
  • [Cites] Genes Dev. 2005 Feb 15;19(4):489-501 [15713842.001]
  • [Cites] Mol Ther. 2005 Apr;11(4):591-9 [15771961.001]
  • [Cites] J Virol. 2005 Apr;79(8):4610-8 [15795247.001]
  • [Cites] J Virol. 2005 Jun;79(11):6610-9 [15890899.001]
  • [Cites] EMBO Rep. 2005 Jun;6(6):520-4 [15940285.001]
  • [Cites] Lancet. 2005 Aug 13-19;366(9485):549-55 [16099290.001]
  • [Cites] Curr Gene Ther. 2005 Aug;5(4):367-73 [16101511.001]
  • [Cites] Development. 2005 Nov;132(21):4645-52 [16224044.001]
  • [Cites] EMBO J. 2007 Jan 24;26(2):412-23 [17245431.001]
  • [Cites] EMBO J. 2007 Jan 24;26(2):424-35 [17245432.001]
  • [Cites] Cell. 2007 Feb 23;128(4):669-81 [17320505.001]
  • [Cites] Cell. 2007 Feb 23;128(4):693-705 [17320507.001]
  • [Cites] J Virol. 2007 Mar;81(6):2592-604 [17202206.001]
  • [Cites] Oncogene. 2007 Feb 26;26(9):1351-6 [17322921.001]
  • [Cites] Subcell Biochem. 2007;41:371-96 [17484137.001]
  • [Cites] Nature. 2007 May 24;447(7143):407-12 [17522673.001]
  • [Cites] Cell. 2007 Oct 5;131(1):46-57 [17923087.001]
  • [Cites] Nat Rev Drug Discov. 2006 Sep;5(9):769-84 [16955068.001]
  • (PMID = 18094192.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA071515; United States / NCI NIH HHS / CA / CA06927; United States / NCI NIH HHS / CA / CA71515; United States / NINDS NIH HHS / NS / NS053666; United States / NINDS NIH HHS / NS / R21 NS053666; United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Chromosomal Proteins, Non-Histone; 0 / DAXX protein, human; 0 / DNA Primers; 0 / Histone Deacetylase Inhibitors; 0 / Nuclear Proteins; 0 / Proteins; 0 / RNA, Small Interfering; 107283-02-3 / heterochromatin-specific nonhistone chromosomal protein HP-1; EC 3.5.1.98 / Histone Deacetylases
  • [Other-IDs] NLM/ PMC2258957
  •  go-up   go-down


57. Sun HY, McNally MT, Jackson VE, Grossberg SE: Urea-nuclease treatment of concentrated retrovirions preserves viral RNA and removes polymerase chain reaction-amplifiable cellular RNA and DNA. J Virol Methods; 2006 Nov;137(2):304-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The utility of the method was demonstrated with two different retroviruses, a Moloney murine leukemia virus variant and Rous sarcoma virus, such that viral RNA thus purified was shown to be free of contamination by PCR-amplifiable cellular GAPDH mRNA and ribosomal RNA.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. UREA .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genome Res. 2000 May;10(5):672-8 [10810090.001]
  • [Cites] J Virol. 2001 Jul;75(13):6173-82 [11390619.001]
  • [Cites] Virology. 2003 Mar 30;308(1):83-91 [12706092.001]
  • [Cites] Biotechniques. 2003 Nov;35(5):920-2, 924, 926 [14628663.001]
  • [Cites] Exp Cell Res. 1968 Mar;49(3):666-78 [5646604.001]
  • [Cites] Biochem Biophys Res Commun. 1975 Dec 15;67(4):1391-400 [1201093.001]
  • [Cites] Annu Rev Biochem. 1977;46:931-54 [332067.001]
  • [Cites] J Virol. 1986 Nov;60(2):450-9 [2430109.001]
  • [Cites] Mol Biol Evol. 1985 Nov;2(6):455-68 [2835576.001]
  • [Cites] J Virol. 1989 Jan;63(1):64-75 [2462064.001]
  • [Cites] Virology. 1993 Feb;192(2):501-11 [8421897.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1544-8 [7509077.001]
  • [Cites] Methods Enzymol. 1994;228:640-58 [8047022.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 May 28;93(11):5177-84 [8643549.001]
  • [Cites] J Exp Med. 1996 Mar 1;183(3):1161-72 [8642258.001]
  • [Cites] Virology. 1997 Mar 31;230(1):125-33 [9126268.001]
  • [Cites] Virology. 1997 Mar 31;230(1):134-44 [9126269.001]
  • [Cites] Virology. 1998 Oct 10;250(1):135-9 [9770427.001]
  • [Cites] Res Virol. 1997 May-Jun;148(3):191-206 [9201810.001]
  • (PMID = 16920200.001).
  • [ISSN] 0166-0934
  • [Journal-full-title] Journal of virological methods
  • [ISO-abbreviation] J. Virol. Methods
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA078709-09; United States / NIAID NIH HHS / AI / R01 AI032710; United States / NCI NIH HHS / CA / R01-CA078709; United States / NIAID NIH HHS / AI / R01-AI-32710; United States / NCI NIH HHS / CA / CA078709-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / RNA, Ribosomal; 0 / RNA, Viral; 63231-63-0 / RNA; 8W8T17847W / Urea; 9007-49-2 / DNA; EC 1.2.1.- / Glyceraldehyde-3-Phosphate Dehydrogenases; EC 3.1.- / Deoxyribonucleases; EC 3.1.27.5 / Ribonuclease, Pancreatic
  • [Other-IDs] NLM/ NIHMS74078; NLM/ PMC2575689
  •  go-up   go-down


58. Babel AR, Bruce J, Young JA: The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion. PLoS One; 2007 Jan 24;2(1):e171
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.
  • The avian sarcoma and leukosis virus (ASLV) envelope glycoprotein (Env) is activated to trigger fusion by a two-step mechanism involving receptor-priming and low pH fusion activation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3520-6 [11264341.001]
  • [Cites] J Virol. 1997 Oct;71(10):7814-9 [9311868.001]
  • [Cites] J Virol. 2003 Jun;77(12):6709-19 [12767991.001]
  • [Cites] J Virol. 2003 Oct;77(19):10504-14 [12970435.001]
  • [Cites] J Virol. 2004 Apr;78(7):3753-62 [15016895.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] Biophys J. 2004 Nov;87(5):3291-8 [15339808.001]
  • [Cites] Cell. 1985 Feb;40(2):431-9 [3967299.001]
  • [Cites] Cell. 1986 May 9;45(3):365-74 [3009025.001]
  • [Cites] Virology. 1986 Jul 30;152(2):343-54 [3014723.001]
  • [Cites] J Virol. 1988 Jan;62(1):75-83 [2824857.001]
  • [Cites] Annu Rev Genet. 1990;24:409-45 [1708222.001]
  • [Cites] J Virol. 1993 Apr;67(4):1811-6 [8383211.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11617-22 [9326659.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] J Virol. 1998 Apr;72(4):3259-67 [9525653.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] J Virol. 1999 Apr;73(4):3087-94 [10074159.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72 [10449786.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] Curr Top Microbiol Immunol. 2005;285:25-66 [15609500.001]
  • [Cites] J Virol. 2005 Mar;79(6):3488-99 [15731243.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 [15937118.001]
  • [Cites] J Virol. 2005 Aug;79(16):10408-19 [16051833.001]
  • [Cites] J Virol. 2005 Oct;79(20):12969-78 [16188999.001]
  • [Cites] Virology. 2006 Jan 5;344(1):25-9 [16364732.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5531-6 [16567631.001]
  • [Cites] J Virol. 2000 Feb;74(4):1686-93 [10644338.001]
  • [Cites] J Virol. 2000 Apr;74(8):3572-78 [10729132.001]
  • [Cites] J Virol. 2000 Apr;74(8):3731-9 [10729148.001]
  • [Cites] Virology. 2000 Aug 1;273(2):364-73 [10915607.001]
  • [Cites] J Virol. 2000 Oct;74(20):9738-41 [11000247.001]
  • [Cites] J Virol. 2000 Dec;74(24):11490-4 [11090145.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] J Virol. 2001 Jan;75(2):726-37 [11134286.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1995 Nov;69(11):6643-51 [7474073.001]
  • [Cites] J Virol. 1997 May;71(5):3458-65 [9094617.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • (PMID = 17245447.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01-CA22443; United States / NIAID NIH HHS / AI / R01 AI053668; United States / NCI NIH HHS / CA / CA70810; United States / NIAID NIH HHS / AI / AI053668; United States / NCI NIH HHS / CA / P01 CA022443; United States / NCI NIH HHS / CA / T32 CA009135; United States / NCI NIH HHS / CA / R01 CA070810
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Peptides; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC1764858
  • [General-notes] NLM/ Original DateCompleted: 20070723
  •  go-up   go-down


59. Purdy JG, Flanagan JM, Ropson IJ, Rennoll-Bankert KE, Craven RC: Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. J Virol; 2008 Jun;82(12):5951-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To test the roles of specific MHR residues in mature capsid assembly, an in vitro system was developed that allowed for the first-time formation of Rous sarcoma virus CA into structures resembling authentic capsids.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-Tryptophan .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Phys Rev Lett. 2006 Feb 24;96(7):078102 [16606144.001]
  • [Cites] Virology. 2006 Apr 10;347(2):364-71 [16427108.001]
  • [Cites] J Virol. 2006 Jun;80(12):5716-22 [16731910.001]
  • [Cites] J Virol. 2007 Feb;81(3):1288-96 [17093186.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] J Virol. 2007 Jul;81(13):6957-72 [17442718.001]
  • [Cites] Biophys J. 2007 Aug 15;93(4):1264-76 [17526561.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Oct;51(10):3574-81 [17638699.001]
  • [Cites] J Mol Biol. 2007 Oct 19;373(2):355-66 [17826792.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] Biophys J. 2008 Jan 15;94(2):L8-10 [17981892.001]
  • [Cites] Biochemistry. 2008 Feb 26;47(8):2289-97 [18220423.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] Virology. 2008 Jun 20;376(1):191-8 [18433823.001]
  • [Cites] J Mol Biol. 1999 Feb 12;286(1):83-93 [9931251.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] EMBO J. 1999 Mar 1;18(5):1124-36 [10064580.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] Mol Cell. 2005 Jan 21;17(2):166-7 [15664185.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] J Biol Chem. 2005 Feb 25;280(8):6792-801 [15569685.001]
  • [Cites] Protein Expr Purif. 2005 May;41(1):207-34 [15915565.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):678-82 [16041386.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):671-7 [16041387.001]
  • [Cites] Virology. 2005 Sep 15;340(1):33-45 [16045955.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Virol. 2005 Nov;79(22):14271-81 [16254362.001]
  • [Cites] J Virol. 2005 Dec;79(23):14498-506 [16282449.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Virol. 2000 Feb;74(3):1168-77 [10627527.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Biophys J. 2000 Mar;78(3):1551-60 [10692339.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Mol Biol. 2001 Mar 2;306(4):783-97 [11243788.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Virol. 2001 Oct;75(19):9357-66 [11533199.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] J Virol. 2002 Jul;76(14):6900-8 [12072491.001]
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):225-37 [12473464.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Mol Biol. 2003 Apr 11;327(5):1013-20 [12662926.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60 [14573704.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] Mol Gen Genet. 1968 May 17;101(4):333-45 [5684818.001]
  • [Cites] J Mol Biol. 1974 Nov 15;89(4):755-8 [4449130.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Jun;76(6):2745-9 [288062.001]
  • [Cites] J Biol Chem. 1985 Aug 5;260(16):9479-90 [4019481.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] Biophys J. 1993 Mar;64(3):824-35 [8471727.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Virol. 1996 Jun;70(6):3440-8 [8648676.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] Virology. 1997 Nov 10;238(1):79-84 [9375011.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):345-53 [16259620.001]
  • (PMID = 18400856.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / CA100322
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins; 8DUH1N11BX / Tryptophan
  • [Other-IDs] NLM/ PMC2395126
  •  go-up   go-down


60. Mirmohammadsadegh A, Hassan M, Bardenheuer W, Marini A, Gustrau A, Nambiar S, Tannapfel A, Bojar H, Ruzicka T, Hengge UR: STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases. J Invest Dermatol; 2006 Oct;126(10):2272-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Altered signaling pathways are key regulators of cellular functions in tumor cells.
  • Constitutive activation of signal transducer and activator of transcription (STAT)3 and -5 may be involved in tumor formation and progression.
  • rEGF-induced activation of STAT5 occurred in vitro through the non-receptor tyrosine kinases transforming gene (src) of Rous Sarcoma virus and Janus kinase 1.
  • [MeSH-minor] Aged. Aged, 80 and over. Apoptosis. Cell Line, Tumor. DNA / metabolism. Epidermal Growth Factor / pharmacology. Female. Humans. Janus Kinase 1. Male. Middle Aged. Phosphorylation. Proto-Oncogene Proteins c-bcl-2 / analysis. Receptor, Epidermal Growth Factor / analysis. Signal Transduction

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16741510.001).
  • [ISSN] 0022-202X
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins c-bcl-2; 0 / STAT5 Transcription Factor; 62229-50-9 / Epidermal Growth Factor; 9007-49-2 / DNA; EC 2.7.010.2 / JAK1 protein, human; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 2.7.10.2 / Janus Kinase 1; EC 2.7.10.2 / src-Family Kinases
  •  go-up   go-down


61. Wessler S, Otto C, Wilck N, Stangl V, Fritzemeier KH: Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity. J Steroid Biochem Mol Biol; 2006 Jan;98(1):25-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment of breast cancer cells and osteosarcoma cells with estradiol, estren, substance A and substance B led to non-genomic activation of Akt (protein kinase B) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascades mediated by Src (Rous Sarcoma Virus, non-receptor tyrosine kinase) and phosphatidylinositol-3-kinase (PI3K) stimulation.
  • [MeSH-minor] Animals. Aorta / drug effects. Blotting, Western. Bone Neoplasms / drug therapy. Bone Neoplasms / metabolism. Bone Neoplasms / pathology. Breast Neoplasms / drug therapy. Breast Neoplasms / metabolism. Breast Neoplasms / pathology. Estradiol / pharmacology. Humans. Immunoprecipitation. Ligands. Male. Mitogen-Activated Protein Kinase 1 / metabolism. Mitogen-Activated Protein Kinase 3 / metabolism. Osteosarcoma / drug therapy. Osteosarcoma / metabolism. Osteosarcoma / pathology. Phosphatidylinositol 3-Kinases / metabolism. Phosphorylation. Proto-Oncogene Proteins c-akt / metabolism. Rats. Rats, Wistar. Tumor Cells, Cultured. Vasodilation / drug effects. src-Family Kinases / metabolism

  • Hazardous Substances Data Bank. ESTRADIOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16203130.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ligands; 0 / Receptors, Estrogen; 4TI98Z838E / Estradiol; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.137 / PIK3CA protein, human; EC 2.7.10.2 / src-Family Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3
  •  go-up   go-down


62. Badowski C, Pawlak G, Grichine A, Chabadel A, Oddou C, Jurdic P, Pfaff M, Albigès-Rizo C, Block MR: Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol Biol Cell; 2008 Feb;19(2):633-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In Rous sarcoma virus (RSV)-transformed baby hamster kidney (BHK) cells, invadopodia can self-organize into rings and belts, similarly to podosome distribution during osteoclast differentiation.
  • [MeSH-minor] Animals. Calpain / antagonists & inhibitors. Cell Communication / drug effects. Cell Movement / drug effects. Cell Transformation, Viral / drug effects. Cricetinae. Enzyme Activation / drug effects. Extracellular Matrix / drug effects. Extracellular Matrix / metabolism. Extracellular Signal-Regulated MAP Kinases / metabolism. HeLa Cells. Humans. Mice. Mutant Proteins / metabolism. Phosphoproteins / metabolism. Phosphorylation / drug effects. Phosphotyrosine / metabolism. Protein Kinase Inhibitors / pharmacology. Rous sarcoma virus / metabolism. Vanadates / pharmacology

  • PhosphoSitePlus. gene/protein/disease-specific - PhosphoSitePlus® - comprehensive post-translational modification resource .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2004 Jul 2;279(27):27965-70 [15107421.001]
  • [Cites] Front Biosci. 2004 May 1;9:1944-53 [14977600.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Aug;5(8):647-57 [15366708.001]
  • [Cites] Physiol Rev. 2004 Oct;84(4):1315-39 [15383653.001]
  • [Cites] J Cell Biol. 1984 Nov;99(5):1696-705 [6436255.001]
  • [Cites] Exp Cell Res. 1985 Jul;159(1):141-57 [2411576.001]
  • [Cites] Exp Cell Res. 1987 Mar;169(1):202-14 [3028844.001]
  • [Cites] Blood. 1988 Aug;72(2):830-3 [3135866.001]
  • [Cites] J Cell Sci. 1989 Sep;94 ( Pt 1):85-99 [2482298.001]
  • [Cites] J Cell Biol. 1990 Sep;111(3):1059-68 [2118142.001]
  • [Cites] J Cell Sci. 1991 Jun;99 ( Pt 2):213-25 [1885668.001]
  • [Cites] J Cell Biol. 1992 Dec;119(5):1309-25 [1447304.001]
  • [Cites] J Clin Invest. 1993 Jun;91(6):2791-5 [8514886.001]
  • [Cites] Mol Cell Biol. 1993 Aug;13(8):4648-56 [7687742.001]
  • [Cites] Biochem Biophys Res Commun. 1994 Mar 30;199(3):1237-44 [8147865.001]
  • [Cites] J Biol Chem. 1995 Mar 10;270(10):5039-47 [7534286.001]
  • [Cites] Mol Cell Biol. 1995 May;15(5):2635-45 [7537852.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9648-53 [10449748.001]
  • [Cites] J Cell Physiol. 2005 Jan;202(1):285-94 [15389601.001]
  • [Cites] J Cell Biol. 2005 Jan 31;168(3):441-52 [15684033.001]
  • [Cites] J Cell Sci. 2005 May 15;118(Pt 10):2079-82 [15890982.001]
  • [Cites] Mol Cancer Res. 2005 Jun;3(6):307-15 [15972849.001]
  • [Cites] J Cell Sci. 2005 Jul 1;118(Pt 13):2901-11 [15976449.001]
  • [Cites] Cancer Res. 2006 Mar 15;66(6):3034-43 [16540652.001]
  • [Cites] Eur J Cell Biol. 2006 Apr;85(3-4):159-64 [16546558.001]
  • [Cites] Eur J Cell Biol. 2006 Apr;85(3-4):195-202 [16546562.001]
  • [Cites] Exp Cell Res. 2006 May 1;312(8):1240-53 [16442522.001]
  • [Cites] J Cell Sci. 2006 May 1;119(Pt 9):1914-25 [16636076.001]
  • [Cites] J Cell Sci. 2006 Jun 1;119(Pt 11):2375-85 [16723743.001]
  • [Cites] Mol Biol Cell. 2006 Jul;17(7):2882-95 [16611741.001]
  • [Cites] Int J Biochem Cell Biol. 2006;38(11):1875-92 [16790362.001]
  • [Cites] Eur J Cell Biol. 2006 Dec;85(12):1217-31 [17010475.001]
  • [Cites] J Cell Sci. 2006 Dec 1;119(Pt 23):4878-88 [17105771.001]
  • [Cites] J Cell Sci. 2007 Jan 1;120(Pt 1):137-48 [17164291.001]
  • [Cites] Trends Cell Biol. 2007 Mar;17(3):107-17 [17275303.001]
  • [Cites] Eur J Cell Biol. 2007 Apr;86(4):189-206 [17343955.001]
  • [Cites] J Biol Chem. 1997 Aug 1;272(31):19248-52 [9235918.001]
  • [Cites] J Biol Chem. 1998 Jul 17;273(29):18623-32 [9660836.001]
  • [Cites] Oncogene. 1999 Aug 5;18(31):4440-9 [10442635.001]
  • [Cites] J Cell Biol. 2000 Mar 6;148(5):957-70 [10704446.001]
  • [Cites] J Biol Chem. 2000 Apr 21;275(16):11993-2002 [10766830.001]
  • [Cites] J Cell Biol. 2000 Jul 24;150(2):377-89 [10908579.001]
  • [Cites] J Biol Chem. 2000 Sep 1;275(35):27155-64 [10823820.001]
  • [Cites] J Cell Sci. 2000 Dec;113 Pt 23:4165-76 [11069762.001]
  • [Cites] J Biol Chem. 2001 Jun 29;276(26):23341-8 [11319218.001]
  • [Cites] Oncogene. 2001 Oct 1;20(44):6459-72 [11607845.001]
  • [Cites] J Cell Sci. 2001 Aug;114(Pt 15):2775-86 [11683411.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):161-6 [11782545.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):669-74 [11830518.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45115-21 [12235133.001]
  • [Cites] Mol Biol Cell. 2003 Feb;14(2):407-16 [12589043.001]
  • [Cites] Mol Biol Cell. 2003 Mar;14(3):1074-84 [12631724.001]
  • [Cites] J Biol Chem. 2003 May 9;278(19):16844-51 [12615925.001]
  • [Cites] Mol Biol Cell. 2003 Jun;14(6):2482-91 [12808045.001]
  • [Cites] Trends Cell Biol. 2003 Jul;13(7):376-85 [12837608.001]
  • [Cites] Mol Cell Biol. 2003 Oct;23(19):6809-22 [12972601.001]
  • [Cites] Nat Cell Biol. 2004 Feb;6(2):154-61 [14743221.001]
  • [Cites] Mol Cell Biol. 2004 Sep;24(18):8113-33 [15340073.001]
  • (PMID = 18045996.001).
  • [ISSN] 1939-4586
  • [Journal-full-title] Molecular biology of the cell
  • [ISO-abbreviation] Mol. Biol. Cell
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mutant Proteins; 0 / Paxillin; 0 / Phosphoproteins; 0 / Protein Kinase Inhibitors; 21820-51-9 / Phosphotyrosine; 3WHH0066W5 / Vanadates; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.4.22.- / Calpain
  • [Other-IDs] NLM/ PMC2230606
  •  go-up   go-down


63. Maślikowski BM, Néel BD, Wu Y, Wang L, Rodrigues NA, Gillet G, Bédard PA: Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer. BMC Cancer; 2010 Feb 12;10:41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we took advantage of several strains of the Rous sarcoma virus (RSV) to characterize the patterns of v-Src-dependent gene expression in two different primary cell types, namely chicken embryo fibroblasts (CEF) and chicken neuroretinal (CNR) cells.
  • We identified a common set of v-Src regulated genes and assessed if their expression is associated with disease-free survival using several independent human tumor data sets.
  • A clustering enrichment regime using the CSR genes and two independent breast tumor data-sets was used to identify a 42-gene aggressive tumor gene signature.
  • The aggressive gene signature was tested for its prognostic value by conducting survival analyses on six additional tumor data sets.
  • Within the CSR gene set, a group of 42 v-Src inducible genes was associated with reduced disease- and metastasis-free survival in several independent patient cohorts with breast or lung cancer.
  • The identification of these genes provides a set of biomarkers of aggressive tumor behavior and a framework for the study of cancer cells characterized by elevated Src kinase activity.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 1999 Mar 1;80(5):731-7 [10048975.001]
  • [Cites] Nat Genet. 1999 Feb;21(2):187-90 [9988270.001]
  • [Cites] J Biol Chem. 1999 Mar 19;274(12):7936-40 [10075689.001]
  • [Cites] Oncogene. 2004 Nov 4;23(52):8455-63 [15378015.001]
  • [Cites] J Cell Biol. 2005 Jan 31;168(3):441-52 [15684033.001]
  • [Cites] J Biol Chem. 2005 Feb 18;280(7):5836-42 [15579908.001]
  • [Cites] Mol Cancer Ther. 2005 Feb;4(2):217-24 [15713893.001]
  • [Cites] Lancet. 2005 Feb 19-25;365(9460):671-9 [15721472.001]
  • [Cites] Bioinformatics. 2005 Apr 15;21(8):1592-5 [15572472.001]
  • [Cites] Nature. 2005 Jul 28;436(7050):518-24 [16049480.001]
  • [Cites] Mol Cell Biol. 2005 Nov;25(22):9960-72 [16260610.001]
  • [Cites] Nature. 2006 Jan 19;439(7074):353-7 [16273092.001]
  • [Cites] Breast Cancer Res. 2005;7(6):R953-64 [16280042.001]
  • [Cites] J Natl Cancer Inst. 2006 Feb 15;98(4):262-72 [16478745.001]
  • [Cites] Exp Cell Res. 2006 Apr 1;312(6):760-9 [16434035.001]
  • [Cites] J Cell Sci. 2006 May 1;119(Pt 9):1691-702 [16595550.001]
  • [Cites] BMC Cancer. 2006;6:105 [16638134.001]
  • [Cites] Breast Cancer Res Treat. 2006 Jun;97(3):263-74 [16333527.001]
  • [Cites] Mol Biol Cell. 2006 Jul;17(7):2882-95 [16611741.001]
  • [Cites] J Biol Chem. 2006 Sep 8;281(36):26424-36 [16835221.001]
  • [Cites] Neurosci Res. 2006 Sep;56(1):111-8 [16839635.001]
  • [Cites] Nat Cell Biol. 1999 May;1(1):69-71 [10559867.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):27-30 [10592173.001]
  • [Cites] Mol Cell Biol. 2000 Dec;20(24):9271-80 [11094078.001]
  • [Cites] Oncogene. 2000 Nov 20;19(49):5636-42 [11114744.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6 [11134512.001]
  • [Cites] Breast Cancer Res. 2000;2(3):203-10 [11250711.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 [11309499.001]
  • [Cites] Biochem Biophys Res Commun. 2001 May 18;283(4):854-61 [11350063.001]
  • [Cites] Oncogene. 2001 Apr 26;20(18):2301-13 [11402325.001]
  • [Cites] Mol Biol Cell. 2001 Jun;12(6):1859-68 [11408591.001]
  • [Cites] Genome Biol. 2001;2(8):RESEARCH0032 [11532216.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Mol Cell. 2002 May;9(5):1031-44 [12049739.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7256-65 [12370817.001]
  • [Cites] Hepatology. 2003 Apr;37(4):742-4 [12668964.001]
  • [Cites] Cancer Res. 2006 Nov 1;66(21):10292-301 [17079448.001]
  • [Cites] Nature. 2006 Nov 30;444(7119):633-7 [17136093.001]
  • [Cites] Nature. 2006 Nov 30;444(7119):638-42 [17136094.001]
  • [Cites] Genes Dev. 2007 Jan 1;21(1):43-8 [17210786.001]
  • [Cites] Cancer Res. 2007 Mar 1;67(5):1979-87 [17332325.001]
  • [Cites] Anticancer Drugs. 2007 Apr;18(4):371-5 [17351389.001]
  • [Cites] Apoptosis. 2007 Apr;12(4):731-41 [17219054.001]
  • [Cites] Mol Cell Biol. 2007 Jun;27(11):3920-35 [17403902.001]
  • [Cites] Virology. 2007 Jul 20;364(1):10-20 [17448514.001]
  • [Cites] FEBS Lett. 2007 Aug 7;581(20):3777-82 [17631293.001]
  • [Cites] Exp Cell Res. 2007 Oct 1;313(16):3432-45 [17714703.001]
  • [Cites] Genome Res. 2007 Oct;17(10):1537-45 [17785539.001]
  • [Cites] BMC Cancer. 2007;7:182 [17894856.001]
  • [Cites] J Biomol Tech. 2007 Dec;18(5):321-30 [18166675.001]
  • [Cites] Curr Opin Cell Biol. 2008 Apr;20(2):235-41 [18337078.001]
  • [Cites] J Neurotrauma. 2008 Jun;25(6):695-707 [18457515.001]
  • [Cites] BMC Genomics. 2008;9:394 [18717985.001]
  • [Cites] Int J Biochem Cell Biol. 2009 Mar;41(3):482-6 [18378184.001]
  • [Cites] Genes Chromosomes Cancer. 2009 Apr;48(4):330-9 [19145645.001]
  • [Cites] Cancer Cell. 2009 Jul 7;16(1):67-78 [19573813.001]
  • [Cites] Mol Cell Biol. 1984 Sep;4(9):1834-42 [6092942.001]
  • [Cites] Cancer Res. 2003 Apr 1;63(7):1667-75 [12670921.001]
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Genome Biol. 2003;4(10):R70 [14519205.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):2962-8 [15126326.001]
  • [Cites] J Am Coll Surg. 2004 Jun;198(6):953-9 [15194078.001]
  • [Cites] Cell. 2004 Jun 25;117(7):927-39 [15210113.001]
  • [Cites] J Cell Sci. 2004 Sep 15;117(Pt 20):4849-61 [15340010.001]
  • [Cites] J Biol Chem. 2004 Oct 29;279(44):46113-21 [15326164.001]
  • [Cites] Cell. 1977 Aug;11(4):881-90 [196765.001]
  • [Cites] Cell. 1977 Aug;11(4):891-9 [196766.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 1980;44 Pt 2,:983-90 [6253230.001]
  • [Cites] J Cell Physiol. 1981 Dec;109(3):373-85 [6172432.001]
  • [Cites] Adv Exp Med Biol. 1982;158:115-22 [6297273.001]
  • [Cites] Differentiation. 1983;24(2):131-9 [6309590.001]
  • [Cites] EMBO J. 1985 Jun;4(6):1435-40 [3875482.001]
  • [Cites] Mol Cell Biol. 1985 Nov;5(11):3194-8 [3018507.001]
  • [Cites] J Virol. 1987 Feb;61(2):354-60 [3027366.001]
  • [Cites] Cell. 1987 May 8;49(3):321-8 [3032449.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Oct;84(19):6715-9 [2821543.001]
  • [Cites] Mol Cell Biol. 1988 Apr;8(4):1414-20 [2837640.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Feb;86(4):1178-82 [2537491.001]
  • [Cites] Oncogene. 1991 Feb;6(2):245-56 [1705687.001]
  • [Cites] J Virol. 1991 Jul;65(7):3728-37 [2041092.001]
  • [Cites] Nature. 1991 Aug 15;352(6336):635-8 [1907719.001]
  • [Cites] Oncogene. 1991 Oct;6(10):1825-33 [1656364.001]
  • [Cites] Genes Dev. 1992 Apr;6(4):545-56 [1313769.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 May 15;89(10):4236-9 [1584758.001]
  • [Cites] J Clin Invest. 1993 Jan;91(1):53-60 [7678609.001]
  • [Cites] Oncogene. 1993 Mar;8(3):565-74 [8437841.001]
  • [Cites] J Surg Res. 1993 Apr;54(4):293-8 [7687314.001]
  • [Cites] Oncogene. 1994 Feb;9(2):417-23 [7507229.001]
  • [Cites] J Virol. 1994 Jun;68(6):3527-35 [8189491.001]
  • [Cites] Oncogene. 1994 Dec;9(12):3665-73 [7970725.001]
  • [Cites] EMBO J. 1995 Apr 3;14(7):1372-81 [7729415.001]
  • [Cites] Methods Enzymol. 1995;254:77-97 [8531721.001]
  • [Cites] Mol Cell Biol. 1996 Feb;16(2):481-6 [8552074.001]
  • [Cites] Int J Cancer. 1996 Jun 11;66(6):747-52 [8647644.001]
  • [Cites] Mol Cell Biol. 1996 Aug;16(8):4504-11 [8754851.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3028-33 [9096340.001]
  • [Cites] Annu Rev Cell Dev Biol. 1997;13:513-609 [9442882.001]
  • [Cites] Mol Cell Biol. 1998 May;18(5):2545-52 [9566874.001]
  • [Cites] Mol Cell Biol. 1998 May;18(5):2553-8 [9566875.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 [9843981.001]
  • (PMID = 20152043.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / / MOP#10272
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 2.7.10.2 / Oncogene Protein pp60(v-src)
  • [Other-IDs] NLM/ PMC2837010
  •  go-up   go-down


64. Halbert CL, Lam SL, Miller AD: High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum Gene Ther; 2007 Apr;18(4):344-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the strong viral promoters examined, the Rous sarcoma virus (RSV) promoter performed significantly better than a human cytomegalovirus (CMV) promoter in the airway epithelium.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17430088.001).
  • [ISSN] 1043-0342
  • [Journal-full-title] Human gene therapy
  • [ISO-abbreviation] Hum. Gene Ther.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK047754; United States / NHLBI NIH HHS / HL / U01 HL066947; United States / NIDDK NIH HHS / DK / DK47754; United States / NHLBI NIH HHS / HL / HL66947
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 9004-22-2 / Globins; EC 3.1.3.1 / Alkaline Phosphatase
  • [Other-IDs] NLM/ NIHMS652207; NLM/ PMC4285347
  •  go-up   go-down


65. Melder DC, Yin X, Delos SE, Federspiel MJ: A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain. J Virol; 2009 Sep;83(17):8575-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
  • The entry process of the avian sarcoma and leukosis virus (ASLV) family of retroviruses requires first a specific interaction between the viral surface (SU) glycoproteins and a receptor on the cell surface at a neutral pH, triggering conformational changes in the viral SU and transmembrane (TM) glycoproteins, followed by exposure to low pH to complete fusion.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CYSTEINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Feb;74(4):1686-93 [10644338.001]
  • [Cites] J Virol. 1999 Dec;73(12):10051-60 [10559319.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] J Virol. 2001 Jan;75(2):726-37 [11134286.001]
  • [Cites] Nat Struct Biol. 2001 Aug;8(8):715-20 [11473264.001]
  • [Cites] FEBS Lett. 2001 Dec 7;509(2):161-8 [11768384.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] J Virol. 2002 Dec;76(24):12463-72 [12438572.001]
  • [Cites] Biochim Biophys Acta. 2003 Jul 11;1614(1):14-23 [12873762.001]
  • [Cites] Biochim Biophys Acta. 2003 Jul 11;1614(1):104-15 [12873771.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;281:107-36 [12932076.001]
  • [Cites] J Virol. 2004 Feb;78(3):1403-10 [14722295.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] Biophys J. 2004 Nov;87(5):3291-8 [15339808.001]
  • [Cites] Avian Dis. 1979 Jul-Sep;23(3):698-707 [230808.001]
  • [Cites] J Virol. 1995 Dec;69(12):7410-5 [7494245.001]
  • [Cites] Cell. 1996 May 17;85(4):477-8 [8653783.001]
  • [Cites] Annu Rev Cell Dev Biol. 1996;12:627-61 [8970739.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Cell Biol. 1997 Dec 15;139(6):1455-64 [9396751.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Apr;73(4):3054-61 [10074155.001]
  • [Cites] J Virol. 1999 Apr;73(4):3087-94 [10074159.001]
  • [Cites] J Virol. 1999 Oct;73(10):8907-12 [10482652.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] Eur J Biochem. 2004 Dec;271(23-24):4725-36 [15606759.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 [15937118.001]
  • [Cites] Virology. 2006 Jan 5;344(1):25-9 [16364732.001]
  • [Cites] J Virol. 2008 Mar;82(6):3131-4 [18184714.001]
  • [Cites] Crit Rev Biochem Mol Biol. 2008 May-Jun;43(3):189-219 [18568847.001]
  • [Cites] J Virol. 2000 Oct;74(20):9738-41 [11000247.001]
  • (PMID = 19515762.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI022470; United States / NIAID NIH HHS / AI / R01 AI048682; United States / NIAID NIH HHS / AI / AI22470; United States / NIAID NIH HHS / AI / AI48682
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Receptors, Virus; 0 / Tva receptor; 0 / Viral Fusion Proteins; K848JZ4886 / Cysteine
  • [Other-IDs] NLM/ PMC2738199
  •  go-up   go-down


66. Wilusz JE, Beemon KL: The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation. J Virol; 2006 Oct;80(19):9634-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.
  • The Rous sarcoma virus gag gene contains a cis-acting negative regulator of splicing (NRS) element that is implicated in viral polyadenylation regulation.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 2004 Sep;10(9):1388-98 [15317975.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1552-9 [1701407.001]
  • [Cites] Cell. 1988 Jan 29;52(2):221-8 [2830023.001]
  • [Cites] J Virol. 1988 Nov;62(11):4003-8 [2459410.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] Genes Dev. 1993 Oct;7(10):1926-36 [8405999.001]
  • [Cites] Microbiol Rev. 1993 Sep;57(3):511-21 [7902524.001]
  • [Cites] Genes Dev. 1994 Feb 1;8(3):363-75 [7906237.001]
  • [Cites] J Virol. 1996 Feb;70(2):1163-72 [8551577.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] Nature. 1997 Jan 23;385(6614):357-61 [9002523.001]
  • [Cites] Nucleic Acids Res. 1997 Jul 1;25(13):2547-61 [9185563.001]
  • [Cites] J Virol. 1997 Sep;71(9):6526-33 [9261372.001]
  • [Cites] J Virol. 1997 Sep;71(9):6534-40 [9261373.001]
  • [Cites] Mol Cell Biol. 1998 Jun;18(6):3103-11 [9584151.001]
  • [Cites] Nucleic Acids Res. 1998 Jun 15;26(12):2891-8 [9611233.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] Nature. 1998 Sep 3;395(6697):93-6 [9738505.001]
  • [Cites] Nucleic Acids Res. 1998 Dec 1;26(23):5343-50 [9826757.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Mol Cell. 2005 Mar 4;17(5):613-5 [15749011.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] Methods Mol Biol. 1999;118:309-14 [10549533.001]
  • [Cites] Genes Dev. 2000 Feb 15;14(4):403-13 [10691733.001]
  • [Cites] RNA. 2000 Sep;6(9):1197-211 [10999598.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):32371-8 [10934202.001]
  • [Cites] J Virol. 2001 Aug;75(16):7763-8 [11462052.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] Mol Cell Endocrinol. 2002 Apr 25;190(1-2):1-8 [11997173.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Sep;77(17):9378-87 [12915553.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44153-60 [12944400.001]
  • [Cites] J Biol Chem. 2004 Apr 9;279(15):14889-98 [14749332.001]
  • [Cites] Mol Cell Biol. 1990 Feb;10(2):696-704 [2153921.001]
  • [Cites] Cell. 1990 Sep 7;62(5):889-99 [2168293.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • (PMID = 16973567.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA238796
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Heterogeneous-Nuclear Ribonucleoproteins; 0 / Ribonucleoproteins, Small Nuclear
  • [Other-IDs] NLM/ PMC1617230
  •  go-up   go-down


67. Barth RF, Kaur B: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol; 2009 Sep;94(3):299-312
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
  • In this review we will describe eight commonly used rat brain tumor models and their application for the development of novel therapeutic and diagnostic modalities.
  • The 9L gliosarcoma has been used widely and has provided important information relating to brain tumor biology and therapy.
  • This tumor has been used for a variety of studies to evaluate new therapeutic modalities.
  • The Avian Sarcoma Virus (ASV) induced tumors, and a continuous cell line derived from one of them designated RT-2, have been useful for studies in which de novo tumor induction is an important requirement.
  • [MeSH-minor] Animals. Cell Line, Tumor / pathology. Disease Models, Animal. Gene Expression Regulation, Neoplastic. Mice. Rats